Document and Entity Information
Document and Entity Information Document - shares | 3 Months Ended | |
Mar. 31, 2020 | May 08, 2020 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2020 | |
Document Transition Report | false | |
Entity File Number | 001-39050 | |
Entity Registrant Name | OPORTUN FINANCIAL CORPORATION | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 45-3361983 | |
Entity Address, Address Line One | 2 Circle Star Way | |
Entity Address, City or Town | San Carlos, | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 94070 | |
City Area Code | 650 | |
Local Phone Number | 810-8823 | |
Title of 12(b) Security | Common Stock, $0.0001 par value per share | |
Trading Symbol | OPRT | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 27,171,802 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2020 | |
Document Fiscal Period Focus | Q1 | |
Entity Central Index Key | 0001538716 | |
Amendment Flag | false |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2020 | Dec. 31, 2019 |
Statement of Financial Position [Abstract] | ||
Cash and Cash Equivalents | $ 144,836 | $ 72,179 |
Restricted Cash | 61,258 | 63,962 |
Loans receivable at fair value | 1,760,481 | 1,882,088 |
Loans receivable at amortized cost | 0 | 42,546 |
Unamortized deferred origination costs and fees, net | 0 | (103) |
Allowance for loan losses | 0 | 3,972 |
Loans receivable at amortized cost, net | 0 | 38,471 |
Loans Receivable Held-for-sale, Amount | 141 | 715 |
Interest and fees receivable, net | 18,254 | 17,185 |
Right of use assets - operating | 50,973 | 50,503 |
Deferred tax asset | 1,261 | 1,563 |
Other Assets | 80,116 | 75,208 |
Total assets | 2,117,320 | 2,201,874 |
Secured financing | 279,064 | 60,910 |
Asset-backed notes at fair value | 999,113 | 1,129,202 |
Asset-backed notes at amortized cost | 199,602 | 359,111 |
Amount due to whole loan buyer | 33,259 | 33,354 |
Lease liabilities | 53,825 | 53,357 |
Deferred tax liabilities | 24,666 | 24,868 |
Other liabilities | 44,250 | 52,306 |
Total liabilities | 1,633,779 | 1,713,108 |
Preferred stock, $0.0001 par value - 100,000,000 shares authorized at March 31, 2020 and December 31, 2019; 0 shares issued and outstanding at March 31, 2020 and December 31, 2019 | 0 | 0 |
Preferred stock, additional paid-in capital | 0 | 0 |
Common stock, $0.0001 par value - 1,000,000,000 shares authorized at March 31, 2020 and December 31, 2019; 27,403,279 shares issued and 27,143,797 shares outstanding at March 31, 2020; 27,262,639 shares issued and 27,003,157 shares outstanding at December 31, 2019 | 6 | 6 |
Common stock, additional paid-in capital | 421,657 | 418,299 |
Common stock warrants | 63 | 63 |
Accumulated other comprehensive loss | (279) | (162) |
Retained earnings | 68,213 | 76,679 |
Treasury stock at cost, 259,482 shares at March 31, 2020 and December 31, 2019 | (6,119) | (6,119) |
Total stockholders' equity | 483,541 | 488,766 |
Total liabilities and stockholders' equity | $ 2,117,320 | $ 2,201,874 |
Consolidated Balance Sheets Bal
Consolidated Balance Sheets Balance Sheet Equity Captions (Parenthetical) - $ / shares | Mar. 31, 2020 | Dec. 31, 2019 |
Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract] | ||
Preferred Stock, Par or Stated Value Per Share | $ 0.0001 | $ 0.0001 |
Preferred Stock, Shares Authorized | 100,000,000 | 100,000,000 |
Preferred Stock, Shares Issued | 0 | 0 |
Preferred Stock, Shares Outstanding | 0 | 0 |
Common Stock, Par or Stated Value Per Share | $ 0.0001 | $ 0.0001 |
Common Stock, Shares Authorized | 1,000,000,000 | 1,000,000,000 |
Common Stock, Shares, Issued | 27,403,279 | 27,262,639 |
Common Stock, Shares, Outstanding | 27,143,797 | 27,003,157 |
Treasury Stock, Common, Shares | 259,482 | 259,482 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Income Statement [Abstract] | ||
Interest income | $ 150,700 | $ 126,746 |
Non-interest income | 12,728 | 11,582 |
Total revenue | 163,428 | 138,328 |
Interest expense | 16,361 | 14,619 |
Provision (release) for loan losses | 0 | (366) |
Decrease in fair value | (66,469) | (25,416) |
Net revenue | 80,598 | 98,659 |
Technology and facilities | 30,774 | 21,641 |
Sales and marketing | 24,827 | 21,266 |
Personnel | 25,582 | 18,877 |
Outsourcing and professional fees | 13,618 | 13,549 |
General, administrative and other | 3,813 | 3,358 |
Total operating expenses | 98,614 | 78,691 |
Income before taxes | (18,016) | 19,968 |
Income tax expense (benefit) | (4,715) | 5,354 |
Net income (loss) | (13,301) | 14,614 |
Change in post-termination benefit obligation | (117) | (3) |
Total comprehensive income (loss) | (13,418) | 14,611 |
Net income (loss) attributable to common stockholders | $ (13,301) | $ 1,688 |
Earnings Per Share, Basic | $ (0.49) | $ 0.57 |
Earnings Per Share, Diluted | $ (0.49) | $ 0.51 |
Weighted Average Number of Shares Outstanding, Basic | 27,015,730 | 2,938,006 |
Weighted Average Number of Shares Outstanding, Diluted | 27,015,730 | 3,314,387 |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands | Total | Redeemable Preferred Stock [Member] | Warrant [Member] | Common Stock [Member] | Preferred Stock [Member] | APIC - Convertible Preferred Stock [Member] | Warrant [Member] | Common Stock [Member] | APIC - Common Stock [Member] | AOCI Attributable to Parent [Member] | Retained Earnings [Member] | Treasury Stock [Member] |
Shares, Outstanding - Period Start at Dec. 31, 2018 | 14,043,977 | 24,959 | 2,935,249 | |||||||||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest - Period Start at Dec. 31, 2018 | $ 346,549 | $ 16 | $ 257,887 | $ 130 | $ 3 | $ 44,411 | $ (132) | $ 52,662 | $ (8,428) | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 7,317 | |||||||||||
Stock Issued During Period, Value, Stock Options Exercised | 142 | 142 | ||||||||||
APIC, Share-based Payment Arrangement, Increase for Cost Recognition | 1,980 | 1,980 | ||||||||||
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification | (125) | (125) | ||||||||||
Other Comprehensive Income (Loss), Net of Tax | (3) | (3) | ||||||||||
Net Income (Loss) Attributable to Parent | 14,614 | 14,614 | ||||||||||
Shares, Outstanding - Period End at Mar. 31, 2019 | 14,043,977 | 24,959 | 2,942,566 | |||||||||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest - Period End at Mar. 31, 2019 | 363,157 | 16 | 257,887 | 130 | 3 | 46,533 | (135) | 67,151 | (8,428) | |||
Shares, Outstanding - Period Start at Dec. 31, 2019 | 0 | 23,512 | 27,003,157 | |||||||||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest - Period Start at Dec. 31, 2019 | 488,766 | 0 | 0 | 63 | 6 | 418,299 | (162) | 76,679 | (6,119) | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 3,161 | |||||||||||
Stock Issued During Period, Value, Stock Options Exercised | 20 | 20 | ||||||||||
APIC, Share-based Payment Arrangement, Increase for Cost Recognition | 4,151 | 4,151 | ||||||||||
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures | 137,479 | |||||||||||
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | (813) | (813) | ||||||||||
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification | 4,835 | 4,835 | ||||||||||
Other Comprehensive Income (Loss), Net of Tax | (117) | (117) | ||||||||||
Net Income (Loss) Attributable to Parent | (13,301) | (13,301) | ||||||||||
Shares, Outstanding - Period End at Mar. 31, 2020 | 0 | 23,512 | 27,143,797 | |||||||||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest - Period End at Mar. 31, 2020 | $ 483,541 | $ 0 | $ 0 | $ 63 | $ 6 | $ 421,657 | $ (279) | $ 68,213 | $ (6,119) |
Consolidated Statements of Cash
Consolidated Statements of Cash Flow - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Statement of Cash Flows [Abstract] | ||
Net income (loss) | $ (13,301) | $ 14,614 |
Depreciation and amortization | 4,658 | 2,879 |
Fair value adjustment, net | 66,469 | 25,416 |
Origination fees for loans receivable at fair value, net | 1,542 | (106) |
Gain (loss) on loans sale | (7,532) | (7,312) |
Stock-based compensation expense | 4,151 | 1,980 |
Provision (release) for loan losses | 0 | (366) |
Deferred tax provision | 101 | 5,163 |
Other, net | 3,521 | 582 |
Origination of loans sold and held for sale | (74,530) | (70,734) |
Proceeds from sale of loans | 82,636 | 76,046 |
Interest and fee receivable, net | (1,987) | (478) |
Increase (Decrease) in Other Assets | (5,818) | (39,723) |
Increase (Decrease) in amount due to whole loan buyer | (95) | 2,549 |
Increase (Decrease) in Other Liabilities | (7,693) | 36,668 |
Net cash provided by operating activities | 52,122 | 47,178 |
Origination of loans | (314,484) | (300,226) |
Repayments of loan principal for loans | 282,212 | 247,257 |
Purchase of fixed assets | (1,615) | (2,231) |
Capitalization of system development costs | (5,461) | (2,509) |
Net cash used in investing activities | (39,348) | (57,709) |
Borrowings under secured financing | 235,000 | 0 |
Payments of secured financing | (17,001) | 0 |
Repayment of asset-backed notes | (160,001) | 0 |
Repayments of capital lease obligations | (26) | (42) |
Net payments related to stock-based activities | (793) | 143 |
Net cash provided by financing activities | 57,179 | 101 |
Net increase (decrease) in cash and cash equivalents and restricted cash | 69,953 | (10,430) |
Cash and cash equivalents and restricted cash, beginning of period | 136,141 | 129,175 |
Cash and cash equivalents and restricted cash, end of period | 206,094 | 118,745 |
Total cash and cash equivalents and restricted cash | 206,094 | 118,745 |
Cash paid for income taxes, net of refunds | 455 | 142 |
Cash paid for interest and prepayment fees | 16,378 | 13,863 |
Operating Lease, Payments | 4,051 | 3,093 |
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | 3,429 | 44,778 |
Purchases of fixed assets included in accounts payable and accrued liabilities | $ 702 | $ 667 |
Organization and Description of
Organization and Description of the Business | 3 Months Ended |
Mar. 31, 2020 | |
Accounting Policies [Abstract] | |
Organization and Description of Business | 1. Organization and Description of Business Oportun Financial Corporation (together with its subsidiaries, "Oportun" or the " Company") is a technology-powered and mission-driven provider of inclusive, affordable financial services to customers who do not have a credit score, known as credit invisibles, or who may have a limited credit history and are "mis-scored," meaning that the Company believes that traditional credit scores do not properly reflect such customers’ credit worthiness. The Company's primary product offerings are small dollar, unsecured installment loans that are affordably priced and that help customers establish a credit history. The Company has begun to expand beyond its core offering into other financial services that a significant portion of its customers already use, such as auto loans, credit cards and personal loans secured by a vehicle. The Company has developed a proprietary lending platform that enables the Company to underwrite the risk of low-to-moderate income customers that are credit invisible or mis-scored, leveraging data collected through the application process and data obtained from third-party data providers, and a technology platform for application processing, loan accounting and servicing. The Company is headquartered in San Carlos, California. The Company has been certified by the United States Department of the Treasury as a Community Development Financial Institution ("CDFI") since 2009. The Company uses securitization transactions, warehouse facilities and whole loan sales, to finance the principal amount of most of the loans it makes to its customers. Segments Segments are defined as components of an enterprise for which discrete financial information is available and evaluated regularly by the chief operating decision maker ("CODM") in deciding how to allocate resources and in assessing performance. The Company’s Chief Executive Officer and the Company's Chief Financial Officer are collectively considered to be the CODM. The CODM reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. The Company’s operations constitute a single reportable segment. Initial Public Offering On September 30, 2019, the Company completed its initial public offering (“IPO”), in which it issued and sold 4,873,356 shares of common stock and selling stockholders sold 2,314,144 shares of common stock, including the underwriters' over-allotment, at a price of $15.00 per share with net proceeds to the Company of approximately $60.5 million , after deducting underwriting discounts and commissions of $5.1 million and offering expenses paid by the Company of approximately $7.5 million . In connection with the IPO, all 14,043,977 shares of the Company’s outstanding redeemable convertible preferred stock automatically converted into 19,075,167 shares of common stock. Additionally, on September 26, 2019, 3,969 shares of common stock were issued in connection with the cashless exercise of 9,090 Series F-1 convertible preferred stock warrants. O n Se |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2020 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Significant Accounting Policies [Text Block] | 2. Summary of Significant Accounting Policies Basis of Presentation ‑ The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). These statements are unaudited and reflect all normal, recurring adjustments that are, in management's opinion, necessary for the fair presentation of results. The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain prior-period financial information has been reclassified to conform to current period presentation. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this Quarterly Report on Form 10-Q should be read in conjunction with the audited consolidated financial statements and the related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2019 ("the Annual Report"), filed with the Securities and Exchange Commission ("SEC") on February 28, 2020. All share and per share amounts for all periods presented in the accompanying condensed consolidated financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect the Company's one-for-eleven reverse stock split. See "Initial Public Offering" above for additional information. Use of Estimates ‑ The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of income and expenses during the reporting period. These estimates are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from those estimates and assumptions. Accounting Policies - There have been no changes to the Company's significant accounting policies from those described in Part II, Item 8 - Financial Statements and Supplementary Data in the Annual Report, except for the new accounting pronouncements subsequently adopted as noted below. Recently Adopted Accounting Standards Allowance for Loan Losses and Fair Value Option ‑ In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments. This guidance significantly changes the way entities are required to measure credit losses. Under the new standard, estimated credit losses are based upon an expected credit loss approach rather than an incurred loss approach that was previously required. In May 2019, the FASB issued ASU 2019-05, Financial Instruments-Credit Losses (Topic 326): Targeted Transition . This ASU provides an option to irrevocably elect the fair value option applied on an instrument-by-instrument basis for certain financial assets upon the adoption of Topic 326. In November 2019, the FASB issued ASU 2019-10, Financial Instruments - Credit Loss (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) , which deferred the effective date for public filers that are considered smaller reporting companies as defined by the SEC to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted in fiscal years beginning after December 15, 2018, including interim periods in those fiscal years. The Company elected to early adopt ASU 2016-13 and ASU 2019-05 effective January 1, 2020. The Company previously elected the fair value option for all loans originated after January 1, 2018. Upon adoption of ASU 2019-05, the Company elected the fair value option on all loans receivable originated prior to January 1, 2018 that were previously measured at amortized cost. As a result, adoption of ASU 2016-13 did not have impact on the Company's condensed consolidated financial statements and disclosures. The Company made an accounting policy election not to measure an allowance for credit losses on accrued interest receivable amounts as the Company writes off the uncollectible accrued interest receivable balance in a timely manner and makes relevant disclosures. The adoption of ASU 2019-05 and fair value election resulted in (i) the release of the remaining allowance for loan losses on Loans Receivable at Amortized Cost as of December 31, 2019; (ii) recognition of the unamortized net originations fee income as of December 31, 2019; and (iii) measurement of the remaining loans originated prior to January 1, 2018 at fair value. These adjustments resulted in an increase to opening retained earnings as of January 1, 2020 of approximately $4.8 million . ASU 2019-05 does not allow for the fair value option to be elected on our asset-backed notes carried at amortized cost. Fair Value Disclosures ‑ In August 2018, the FASB issued ASU 2018-13, Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement , which amends ASC 820, Fair Value Measurement . This ASU simplifies the disclosure requirements for fair value measurements. The Company adopted this ASU effective January 1, 2020. The simplified disclosure requirements included a new disclosure for the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements and the narrative description of measurement uncertainty. These new disclosure requirements were applied prospectively. Cloud Computing Arrangements - In August 2018, the FASB issued ASU 2018-15, Intangibles-Goodwill and Other-Internal-Use-Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. This ASU aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company adopted the amendments of this ASU effective January 1, 2020 on a prospective basis with no impact upon adoption. All eligible implementation costs related to cloud computing arrangements are now recorded as part of "prepaid expenses" within "Other assets" on the Condensed Consolidated Balance Sheets (Unaudited) . The amortization expense is presented in the same line on the income statement as the fees for the associated hosted service within "Operating expenses" on the Company's Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) , and the cash payments related to implementation of cloud computing arrangements are classified as "cash flows from operating activities" within the Condensed Consolidated Statements of Cash Flow (Unaudited) . Accounting Standards to be Adopted Income Taxes - In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes . This ASU is intended to simplify the accounting for income taxes by removing certain exceptions to the general principles of accounting for income taxes and to improve the consistent application of GAAP for other areas of accounting for income taxes by clarifying and amending existing guidance. The ASU is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the effect that the new guidance will have on its consolidated financial statements and disclosures. Reference rate reform - In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this ASU provide optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform if certain criteria are met. An entity may elect to apply the amendments for contract modifications as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020. The amendments in this ASU must be applied prospectively for all eligible contract modifications. The Company is currently evaluating the effect that the new guidance will have on its consolidated financial statements and disclosures. |
Earnings per Share
Earnings per Share | 3 Months Ended |
Mar. 31, 2020 | |
Earnings Per Share [Abstract] | |
Earnings Per Share [Text Block] | 3. Earnings (Loss) per Share Basic and diluted earnings (loss) per share are calculated as follows: Three Months Ended March 31, (in thousands, except share and per share data) 2020 2019 Net income (loss) $ (13,301 ) $ 14,614 Less: Net income allocated to participating securities (1) — (12,926 ) Net (loss) income attributable to common stockholders $ (13,301 ) $ 1,688 Basic weighted-average common shares outstanding 27,015,730 2,938,006 Weighted average effect of dilutive securities: Stock options — 317,433 Restricted stock units — 46,512 Warrants — 12,436 Diluted weighted-average common shares outstanding 27,015,730 3,314,387 Earnings (loss) per share: Basic $ (0.49 ) $ 0.57 Diluted $ (0.49 ) $ 0.51 (1) In a period of net income, both earnings and dividends (if any) are allocated to participating securities. In a period of net loss, only dividends (if any) are allocated to participating securities. The following common share equivalent securities have been excluded from the calculation of diluted weighted-average common shares outstanding because the effect is anti-dilutive for the periods presented: Three Months Ended March 31, 2020 2019 Stock options 4,086,128 — Restricted stock units 1,757,010 — Warrants 23,512 — Convertible preferred stock — 17,201,639 Total anti-dilutive common share equivalents 5,866,650 17,201,639 Restricted stock units granted with performance criterion were not reflected in the computation of diluted earnings (loss) per share for the three months ended March 31, 2019 as the performance condition was not considered probable. Per the provisions of ASC Topic 260, Earnings Per Share , diluted earnings (loss) per share only reflects those shares that would be issued if the reporting period were the end of the contingency period. Accordingly, total outstanding restricted stock units of 0 and 455,821 were not reflected in the denominator in the computation of diluted earnings per share for the three months ended March 31, 2020 and 2019 . The income available to common stockholders, which is the numerator in calculating diluted earnings per share, does not include any compensation cost related to these restricted stock unit awards for the three months ended March 31, 2019 . |
Variable Interest Entities
Variable Interest Entities | 3 Months Ended |
Mar. 31, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Variable Interest Entity Disclosure | 4. Variable Interest Entities As part of the Company’s overall funding strategy, the Company transfers a pool of designated loans receivable to wholly owned special-purpose subsidiaries ("VIEs") to collateralize certain asset-backed financing transactions. The Company has determined that it is the primary beneficiary of these VIEs because it has the power to direct the activities that most significantly impact the VIEs’ economic performance and the obligation to absorb the losses or the right to receive benefits from the VIEs that could potentially be significant to the VIEs. Such power arises from the Company’s contractual right to service the loans receivable securing the VIEs’ asset-backed debt obligations. The Company has an obligation to absorb losses or the right to receive benefits that are potentially significant to the VIEs because it retains the residual interest of each asset-backed financing transaction either in the form of an asset-backed certificate or as an uncertificated residual interest. Accordingly, the Company includes the VIEs’ assets, including the assets securing the financing transactions, and related liabilities in its consolidated financial statements. Each VIE issues a series of asset-backed securities that are supported by the cash flows arising from the loans receivable securing such debt. Cash inflows arising from such loans receivable are distributed monthly to the transaction’s noteholders and related service providers in accordance with the transaction’s contractual priority of payments. The creditors of the VIEs above have no recourse to the general credit of the Company as the primary beneficiary of the VIEs and the liabilities of the VIEs can only be settled by the respective VIE’s assets. The Company retains the most subordinated economic interest in each financing transaction through its ownership of the respective residual interest in each VIE. The Company has no obligation to repurchase loans receivable that initially satisfied the financing transaction’s eligibility criteria but subsequently became delinquent or a defaulted loans receivable. The following table represents the assets and liabilities of consolidated VIEs recorded on the Company’s Condensed Consolidated Balance Sheets (Unaudited) : March 31, December 31, (in thousands) 2020 2019 Consolidated VIE assets Restricted cash $ 25,963 $ 28,821 Loans receivable at fair value 1,693,903 1,745,465 Loans receivable at amortized cost — 41,747 Interest and fee receivable 17,274 15,874 Total VIE assets 1,737,140 1,831,907 Consolidated VIE liabilities Secured financing (1) 279,999 62,000 Asset-backed notes at fair value 999,113 1,129,202 Asset-backed notes at amortized cost (1) 200,000 360,001 Total VIE liabilities $ 1,479,112 $ 1,551,203 (1) Amounts exclude deferred financing costs. See Note 8 , Borrowings for additional information. |
Loans Receivable at Amortized C
Loans Receivable at Amortized Cost, Net | 3 Months Ended |
Mar. 31, 2020 | |
Receivables [Abstract] | |
Loans Receivable at Amortized Cost | 5. Loans Receivable at Amortized Cost, Net Upon adoption of ASU 2019-05, effective January 1, 2020, the Company elected the fair value option on all loans receivable previously measured at amortized cost as of December 31, 2019. Accordingly, for the three months ended March 31, 2020 , the Company did not have any loans receivable measured at amortized cost. Therefore, the relevant disclosures related to loans receivable at amortized cost, net, such as credit quality information, past due loans receivable, troubled debt restructurings, and allowance for loan losses are not applicable for the three months ended March 31, 2020 . The disclosures below relate to the prior year and are disclosed for comparative period purposes. Loans receivable at amortized cost, net, consisted of the following: March 31, December 31, (in thousands) 2020 2019 Loans receivable at amortized cost $ — $ 42,546 Deferred origination costs and fees, net — (103 ) Allowance for loan losses — (3,972 ) Loans receivable at amortized cost, net $ — $ 38,471 Loans receivable at amortized cost are the unpaid principal balances of the loans. Accrued and unpaid interest and late fees on the loans estimated to be collected from customers are included in interest and fees receivable in the condensed consolidated balance sheets. At December 31, 2019 , accrued and unpaid interest on loans were $0.3 million . Accrued and unpaid late fees were immaterial at December 31, 2019 . Credit Quality Information - The Company uses a proprietary credit scoring algorithm to assess the creditworthiness of individuals who have limited or no credit profile. Data used in the algorithm is obtained from customers, alternative credit reporting agencies, commercially available data sources, as well as information from traditional credit bureaus. The Company’s proprietary credit scoring platform determines the amount and duration of the loan. The amount of the loan is determined based on the credit risk and cash flow of the individual. Lower risk individuals with higher cash flows are eligible for larger loans with longer duration. Higher risk individuals with lower cash flows are eligible for smaller loans with shorter duration. Larger loans typically have lower interest rates than smaller loans. After the loan is disbursed, the Company monitors the credit quality of its loans receivable on an ongoing and a total portfolio basis. The following is a credit quality indicator that the Company uses to monitor its exposure to credit risk, to evaluate allowance for loan losses and help set the Company’s strategy in granting future loans: • Delinquency Status ‑ The delinquency status of the Company’s loan receivables reflects, among other factors, changes in the mix of loans in the portfolio, the quality of receivables, the success of collection efforts and general economic conditions. The recorded investment in loans receivable at amortized cost based on this credit quality indicator was as follows: March 31, December 31, Credit Quality Indicator (in thousands) 2020 2019 Delinquency Status 30-59 days past due $ — $ 2,304 60-89 days past due — 1,615 90-119 days past due — 1,459 $ — $ 5,378 Past Due Loans Receivable - In accordance with the Company’s policy, for loans recorded at amortized cost, income from interest and fees continues to be recorded for loans that are delinquent 90 days or more. The Company addresses the valuation risk on loans recorded at amortized cost that are delinquent 90 days or more by reserving them at 100% . The recorded investment in loans receivable at amortized cost that are 90 or more days delinquent and still accruing income from interest and fees were as follows: March 31, December 31, (in thousands) 2020 2019 Non-TDRs $ — $ 720 TDRs — 739 Total $ — $ 1,459 Troubled Debt Restructurings ("TDR") - For the three months ended March 31, 2019 , TDRs were primarily related to concessions involving interest rate reduction and extension of term. As of December 31, 2019 , TDRs comprised 21% of the Company’s total loan portfolio at amortized cost. The amount of unamortized origination fees, net of origination costs, that were written off as a result of TDR restructurings of loans recorded at amortized cost during the three months ended March 31, 2019 was not material. The Company’s TDR loans receivable at amortized cost based on delinquency status were as follows: March 31, December 31, (in thousands) 2020 2019 TDRs current to 29 days delinquent $ — $ 6,367 TDRs 30 or more days delinquent — 2,462 Total $ — $ 8,829 A loan that has been classified as a TDR remains so until the loan is paid off or charged off. A TDR loan that misses its first two scheduled payments is charged off at the end of the month upon reaching 30 days ' delinquency. A TDR loan that makes the first two scheduled payments is charged off according to the Company’s normal charge-off policy at 120 days ' delinquency. For loans recorded at amortized cost, previously accrued but unpaid interest and fees are also written off when the loan is charged off upon reaching 120 days ' delinquency or when collection is not deemed probable. Information on TDRs that defaulted and were charged off during the periods indicated were as follows: Three Months Ended March 31, (in thousands) 2020 2019 Recorded investment in TDRs that subsequently defaulted and were charged off $ — $ 3,254 Unpaid interest and fees charged off — 419 When a loan recorded at amortized cost is restructured as a TDR, a portion of all of the accrued but unpaid interest and late fees may be forgiven. The following table shows the financial effects of TDRs that occurred during the periods indicated: Three Months Ended March 31, (in thousands) 2020 2019 Contractual interest and fees forgiven $ — $ — Allowance for Loan Losses - For loans receivable at amortized cost, the Company sets the allowance for loan losses on a total portfolio by analyzing historical charge-off rates for the loan portfolio and the credit quality indicators discussed earlier. The provision (release) for loan losses reflects the activity for the applicable period and provides an allowance at a level that management believes is adequate to cover probable loan losses at the balance sheet date. The Company estimates an allowance for loan losses only for loans receivable at amortized cost. Activity in the allowance for loan losses was as follows: Three Months Ended March 31, (in thousands) 2020 2019 Balance - beginning of period $ 3,972 $ 26,326 Adjustment upon adoption of ASU 2019-05 (3,972 ) — Provision (release) for loan losses — (366 ) Loans charged off — (12,083 ) Recoveries — 3,315 Balance - end of period $ — $ 17,192 |
Loans Held for Sale
Loans Held for Sale | 3 Months Ended |
Mar. 31, 2020 | |
Transfers and Servicing [Abstract] | |
Transfers and Servicing of Financial Assets [Text Block] | 6. Loans Held for Sale The originations of loans sold and held for sale during the three months ended March 31, 2020 was $74.5 million and the Company recorded a gain on sale of $7.5 million and servicing revenue of $4.5 million . The originations of loans sold and held for sale during the three months ended March 31, 2019 was $70.7 million and the Company recorded a gain on sale of $7.3 million and servicing revenue of $3.5 million . Whole Loan Sale Program ‑ In November 2014, the Company entered into a whole loan sale agreement with an institutional investor, which agreement has been amended from time to time. The term of the current agreement expires on November 10, 2020. Pursuant to this agreement, the Company has committed to sell at least 10% of its unsecured loan originations, with an option to sell an additional 5% , subject to certain eligibility criteria and minimum and maximum volumes. In addition, in July 2017, the Company entered into a separate whole loan sale arrangement with an institutional investor, which agreement has been amended from time to time, providing for a commitment to sell 100% |
Other Assets
Other Assets | 3 Months Ended |
Mar. 31, 2020 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Other Assets Disclosure [Text Block] | 7. Other Assets Other assets consist of the following: March 31, December 31, (in thousands) 2020 2019 Fixed assets Computer and office equipment $ 10,697 $ 10,432 Furniture and fixtures 10,805 10,768 Purchased software 4,900 4,527 Vehicles 79 171 Leasehold improvements 28,673 27,701 Total cost 55,154 53,599 Less: Accumulated depreciation (33,086 ) (30,765 ) Total fixed assets, net $ 22,068 $ 22,834 System development costs: System development costs $ 42,194 $ 36,795 Less: Accumulated amortization (20,624 ) (18,456 ) Total system development costs, net $ 21,570 $ 18,339 Servicer fee and whole loan receivables 2,295 6,621 Prepaid expenses 16,209 12,217 Tax receivable and other 17,974 15,197 Total other assets $ 80,116 $ 75,208 Fixed Assets Depreciation and amortization expense for the three months ended March 31, 2020 and 2019 was $2.5 million and $1.7 million , respectively. System Development Costs Amortization of system development costs for the three months ended March 31, 2020 and 2019 were $2.2 million and $0.9 million , respectively. System development costs capitalized for the three months ended March 31, 2020 and 2019 were $5.4 million and $2.6 million , respectively. |
Borrowings
Borrowings | 3 Months Ended |
Mar. 31, 2020 | |
Debt Disclosure [Abstract] | |
Debt Disclosure [Text Block] | 8. Borrowings The following table presents information regarding the Company's Secured Financing facility: March 31, 2020 Variable Interest Entity Current Balance Commitment Amount Maturity Date Interest Rate (in thousands) Oportun Funding V, LLC $ 279,064 $ 400,000 10/1/2021 LIBOR (minimum of 0.00%) + 2.45% December 31, 2019 Variable Interest Entity Current Balance Commitment Amount Maturity Date Interest Rate (in thousands) Oportun Funding V, LLC $ 60,910 $ 400,000 10/1/2021 LIBOR (minimum of 0.00%) + 2.45% The Company elected the fair value option for all asset-backed notes issued on or after January 1, 2018. The following table presents information regarding asset-backed notes: March 31, 2020 Variable Interest Entity Initial note amount issued (1) Initial collateral balance (2) Current balance (1) Current collateral balance (2) Weighted average interest rate (3) Original revolving period (in thousands) Asset-backed notes recorded at fair value: Oportun Funding XIII, LLC (Series 2019-A) $ 279,412 $ 294,118 $ 216,255 $ 299,008 3.22 % 3 years Oportun Funding XII, LLC (Series 2018-D) 175,002 184,213 156,504 187,188 4.50 % 3 years Oportun Funding X, LLC (Series 2018-C) 275,000 289,474 245,320 294,090 4.39 % 3 years Oportun Funding IX, LLC (Series 2018-B) 225,001 236,854 195,355 240,866 4.09 % 3 years Oportun Funding VIII, LLC (Series 2018-A) 200,004 222,229 185,679 226,052 3.83 % 3 years Total asset-backed notes recorded at fair value $ 1,154,419 $ 1,226,888 $ 999,113 $ 1,247,204 Asset-backed notes recorded at amortized cost: Oportun Funding VII, LLC (Series 2017-B) $ 200,000 $ 222,231 $ 199,602 $ 225,867 3.51 % 3 years Total asset-backed notes recorded at amortized cost $ 200,000 $ 222,231 $ 199,602 $ 225,867 December 31, 2019 Variable Interest Entity Initial note amount issued (1) Initial collateral balance (2) Current balance (1) Current collateral balance (2) Weighted average interest rate (3) Original revolving period (in thousands) Asset-backed notes recorded at fair value: Oportun Funding XIII, LLC (Series 2019-A) $ 279,412 $ 294,118 $ 251,090 $ 299,813 3.22 % 3 years Oportun Funding XII, LLC (Series 2018-D) 175,002 184,213 178,980 187,447 4.50 % 3 years Oportun Funding X, LLC (Series 2018-C) 275,000 289,474 280,852 294,380 4.39 % 3 years Oportun Funding IX, LLC (Series 2018-B) 225,001 236,854 216,306 241,000 4.09 % 3 years Oportun Funding VIII, LLC (Series 2018-A) 200,004 222,229 201,974 225,945 3.83 % 3 years Total asset-backed notes recorded at fair value $ 1,154,419 $ 1,226,888 $ 1,129,202 $ 1,248,585 Asset-backed notes recorded at amortized cost: Oportun Funding VII, LLC (Series 2017-B) $ 200,000 $ 222,231 $ 199,413 $ 225,925 3.51 % 3 years Oportun Funding VI, LLC (Series 2017-A) 160,001 188,241 159,698 191,223 3.36 % 3 years Total asset-backed notes recorded at amortized cost $ 360,001 $ 410,472 $ 359,111 $ 417,148 (1) Initial note amount issued includes notes retained by the Company as applicable. The current balances are measured at fair value for asset-backed notes recorded at fair value and measured at carrying amount for asset-back notes recorded at amortized cost. (2) Includes the unpaid principal balance of loans receivable, cash, cash equivalents and restricted cash pledged by the Company. (3) Weighted average interest rate excludes notes retained by the Company. On March 9, 2020, the Company redeemed its asset-backed notes (Series 2017-A). An advance under the Company’s VFN was the primary source of funds for the redemption. As of March 31, 2020 , and December 31, 2019 , the Company was in compliance with all covenants and requirements of the Secured Financing facility and asset-backed notes. |
Other Liabilities
Other Liabilities | 3 Months Ended |
Mar. 31, 2020 | |
Other Liabilities Disclosure [Abstract] | |
Other Liabilities Disclosure [Text Block] | 9. Other Liabilities Other liabilities consist of the following: March 31, December 31, (in thousands) 2020 2019 Accounts payable $ 7,843 $ 5,919 Accrued compensation 14,262 22,226 Accrued expenses 17,124 15,110 Taxes payable 1,022 4,233 Accrued interest 3,179 3,842 Other 820 976 Total other liabilities $ 44,250 $ 52,306 |
Stockholders' Equity (Notes)
Stockholders' Equity (Notes) | 3 Months Ended |
Mar. 31, 2020 | |
Equity [Abstract] | |
Stockholders' Equity Note Disclosure [Text Block] | 10. Stockholders' Equity Convertible Preferred Stock - Immediately prior to the completion of the IPO, all 14,043,977 shares of convertible preferred stock were converted into 19,075,167 shares of the Company's common stock. The conversion of all of the Company's convertible preferred stock included an additional 1,873,355 shares of common stock issued for the conversion of the Series G convertible preferred stock to reflect the conversion rate of the Series G convertible preferred stock. The additional 1,873,355 shares issued to Series G convertible preferred stock holders resulted in a $37.5 million reduction to retained earnings and a corresponding increase to additional paid-in capital. There were no shares of convertible preferred stock issued or outstanding as of March 31, 2020 or December 31, 2019 . Preferred Stock - The Board has the authority, without further action by the Company's stockholders, to issue up to 100,000,000 shares of undesignated preferred stock with rights and preferences, including voting rights, designated from time to time by the Board. There were no shares of undesignated preferred stock issued or outstanding as of March 31, 2020 or December 31, 2019 . Common Stock - As of March 31, 2020 and December 31, 2019 , the Company was authorized to issue 1,000,000,000 shares of common stock with a par value of $0.0001 per share. As of March 31, 2020 , 27,403,279 and 27,143,797 shares were issued and outstanding, respectively, and 259,482 shares were held in treasury stock. As of December 31, 2019 , 27,262,639 and 27,003,157 shares were issued and outstanding, respectively, and 259,482 shares were held in treasury stock. Warrants - On September 26, 2019, 3,969 shares of convertible preferred stock were issued in connection with the cashless exercise of 9,090 Series F-1 convertible preferred stock warrants. All 3,969 shares were converted to common stock in connection with the IPO. Additionally, at the closing of the IPO, the outstanding 15,869 Series G convertible preferred stock warrants automatically converted into warrants exercisable for 23,512 shares of common stock. |
Equity Compensation and Other B
Equity Compensation and Other Benefits | 3 Months Ended |
Mar. 31, 2020 | |
Equity [Abstract] | |
Shareholders' Equity and Share-based Payments [Text Block] | 11. Equity Compensation and Other Benefits 2019 Equity Incentive Plan The Company currently has one stockholder-approved plan from which stock-based awards can be issued, which was approved by the Company's stockholders in fiscal year 2019 (the "2019 Plan"). The 2019 Plan became effective on September 25, 2019 and is the successor to the Company's Amended and Restated 2005 Stock Option / Stock Issuance Plan (the "2005 Plan") and the 2015 Stock Option/Stock Issuance Plan (the "2015 Plan," and collectively with the 2005 Plan, the “Previous Plans”). The Previous Plans exist solely to satisfy outstanding options previously granted under those plans. The 2019 Plan provides for the grant of incentive stock options ("ISOs"), nonstatutory stock options ("NSOs"), stock appreciation rights, restricted stock awards, restricted stock unit awards, performance-based awards, and other awards, or collectively, awards. ISOs may be granted only to the Company's employees, including officers, and the employees of its affiliates. All other awards may be granted to the employees, including officers, non-employee directors and consultants and the employees and consultants of the Company's affiliates. The maximum number of shares of Company common stock that may be issued under the 2019 Plan will not exceed 8,677,294 shares. On March 4, 2020, the Company registered an additional 1,350,157 shares of common stock that became issuable under the 2019 Plan by reason of the automatic increase provision. The number of shares reserved under the 2019 Plan will automatically increase on January 1 of each year for a period of ten years commencing on January 1, 2020 and ending on (and including) January 1, 2029, in an amount equal to 5% of the total number of shares of common stock outstanding on December 31 of the preceding year; provided, however that the Board may act prior to January 1st of a given year to provide that the increase for such year will be a lesser amount than the 5% of the total number of shares of common stock. 2019 Employee Stock Purchase Plan In September 2019, the Board adopted, and stockholders approved, the Company's 2019 Employee Stock Purchase Plan (the "ESPP"). The ESPP became effective on September 25, 2019. The purpose of the ESPP is to secure the services of new employees, to retain the services of existing employees and to provide incentives for such individuals to exert maximum efforts toward the Company's success and that of its affiliates. The ESPP includes two components. One component is designed to allow eligible U.S. employees to purchase common stock in a manner that may qualify for favorable tax treatment under Section 423 of the Code. In addition, purchase rights may be granted under a component that does not qualify for such favorable tax treatment when necessary or appropriate to permit participation by eligible employees who are foreign nationals or employed outside of the United States while complying with applicable foreign laws. The maximum aggregate number of shares of common stock that may be issued under the ESPP is 996,217 shares. On March 4, 2020, the Company registered an additional 270,031 shares of common stock reserved for future issuance under the ESPP. The number of shares reserved under the ESPP will automatically increase on January 1 of each year for a period of ten years commencing on January 1, 2020 and ending on (and including) January 1, 2029, in an amount equal to the lesser of (a) 1% of the total number of shares of common stock outstanding on December 31 of the preceding year or (b) 726,186 shares of common stock; provided, however that the Board may act prior to January 1st of a given year to provide that the increase for such year will be a lesser number of shares of common stock. Generally, all regular employees, including executive officers, employed by the Company or by any of its designated affiliates, will be eligible to participate in the ESPP and may contribute, normally through payroll deductions, up to 15% of their earnings (as defined in the ESPP) for the purchase of common stock under the ESPP. Unless otherwise determined by the Board, common stock will be purchased for the accounts of employees participating in the ESPP at a price per share equal to the lower of (a) 85% of the fair market value of a share of the Company's common stock on the first date of an offering or (b) 85% of the fair market value of a share of the common stock on the date of purchase. Stock Options The term of an option may not exceed 10 years as determined by the Board, and each option generally vests over a four-year period with 25% vesting on the first anniversary date of the grant and 1/36th of the remaining amount vesting at monthly intervals thereafter. Option holders are allowed to exercise unvested options to acquire shares. Upon termination of employment, option holders have a period of up to three months in which to exercise any remaining vested options. The Company has the right to repurchase at the original purchase price any unvested but issued common shares upon termination of service. Unexercised options granted to participants who separate from the Company are forfeited and returned to the pool of stock options available for grant. The Company estimates the fair value of stock options granted using the Black-Scholes option-pricing model. The fair value is then amortized ratably over the requisite service periods of the awards, which is generally the vesting period. As of March 31, 2020 , and December 31, 2019 , the Company’s total unrecognized compensation cost related to nonvested stock-based option awards granted to employees was $14.4 million and $10.1 million , respectively, which will be recognized over a weighted-average vesting period of approximately 3.0 years and 2.4 years, respectively. Restricted Stock Units The Company’s restricted stock units ("RSUs") vest upon the satisfaction of time-based criterion of up to four years. The service-based requirement will be satisfied in installments as follows: 25% of the total number of RSUs awarded will have the service-based requirement satisfied during the month in which the 12-month anniversary of the vesting commencement date occurs, and thereafter 1/16th of the total award in a series of 12 successive equal quarterly installments or 1/4th of the total award in a series of three successive equal annual installments following the first anniversary of the initial service vest date. Some awards also include a performance criterion, a liquidity event in connection with the Company's initial public offering or a change in control. The liquidity event requirement will be satisfied as to any then-outstanding RSUs on the first to occur of the following events prior to the expiration date: (1) the closing of a change in control; or (2) the first trading day following the expiration of the lock-up period in connection with an IPO. These RSUs are not considered vested until both criteria have been met, if applicable, and provided that participant is providing continuous service on the vesting date. The performance-based condition of such RSUs was considered probable on the effective date of the IPO completed in September 2019. As a result, $7.9 million of compensation expense was recognized in connection with these performance-based awards upon completion of the IPO. As of March 31, 2020 and December 31, 2019 , the Company's total unrecognized compensation cost related to nonvested restricted stock unit awards granted to employees was $35.8 million and $21.2 million , respectively, which will be recognized over a weighted average vesting period of approximately 3.2 years and 3.0 years, respectively. Stock Option Exchange Offer On August 22, 2019, the Company completed a one-time voluntary stock option exchange offer that allowed eligible participants the opportunity to exchange certain stock options for RSUs, subject to a new vesting schedule (the "RSU Exchange Offer"), or for a cash payment (the "Cash Exchange Offer," and together with the RSU Exchange Offer, the "Exchange Offers"). As a result of the Exchange Offers, options to purchase 1,040,154 shares of the Company’s common stock were accepted for exchange and 455,218 replacement RSUs were issued. The replacement RSUs have a vesting commencement date of August 1, 2019 and vesting schedule of two to four years. The RSUs will first vest on August 1, 2020, with the remainder vesting on a quarterly basis thereafter. The RSUs were granted under, and subject to, the terms and conditions of the 2015 Plan. The incremental compensation cost from the exchange is $3.2 million , recognized over the vesting period of the replacement award. The amount of cash payments provided in the Cash Exchange Offer was insignificant. Stock-based Compensation - Total stock-based compensation expense included in the Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) is as follows: Three Months Ended March 31, (in thousands) 2020 2019 Technology and facilities $ 752 $ 329 Sales and marketing 30 20 Personnel 3,369 1,631 Total stock-based compensation $ 4,151 $ 1,980 The Company accounts for forfeitures as they occur and does not estimate forfeitures as of the award grant date. The Company capitalized compensation expense related to stock-based compensation the three months ended March 31, 2020 and 2019 of $0.1 million and $0.1 million , respectively. Cash flows from the tax benefits for tax deductions resulting from the exercise of stock options in excess of the compensation expense recorded for those options (excess tax benefits) are required to be classified as cash from financing activities. The total income tax benefit recognized in the income statement for share-based compensation arrangements for the three months ended March 31, 2020 was $0.7 million . The Company had no realized excess tax benefits from stock options for the three months ended March 31, 2019 |
Revenue
Revenue | 3 Months Ended |
Mar. 31, 2020 | |
Revenue from Contract with Customer [Abstract] | |
Revenue from Contract with Customer [Text Block] | 12. Revenue Interest Income - Total interest income included in the Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) is as follows: Three Months Ended March 31, (in thousands) 2020 2019 Interest income Interest on loans $ 148,522 $ 124,224 Fees on loans 2,178 2,522 Total interest income 150,700 126,746 Non-interest Income - Total non-interest income included in the Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) is as follows: Three Months Ended March 31, (in thousands) 2020 2019 Non-interest income Gain on loan sales $ 7,532 $ 7,312 Servicing fees 4,451 3,548 Other income 745 722 Total non-interest income $ 12,728 $ 11,582 |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2020 | |
Income Tax Disclosure [Abstract] | |
Income Tax Disclosure [Text Block] | 13. Income Taxes Income tax benefit was $(4.7) million for the three months ended March 31, 2020 , representing an effective tax rate of 26.2% . Income tax expense was $5.4 million for the three months ended March 31, 2019 , representing an effective tax rate of 26.8% . Interest and penalties related to the Company’s unrecognized tax benefits accrued at March 31, 2020 |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 3 Months Ended |
Mar. 31, 2020 | |
Fair Value Disclosures [Abstract] | |
Fair Value Disclosures [Text Block] | 14. Fair Value of Financial Instruments Financial Instruments at Fair Value The Company previously elected the fair value option to account for all loans receivable held for investment that were originated on or after January 1, 2018 (the "Initial Fair Value Loans"), and for all asset-backed notes issued on or after January 1, 2018 (the "Fair Value Notes"). Upon adoption of ASU 2019-05, effective January 1, 2020, the Company elected the fair value option on all loans receivable previously measured at amortized cost (the "Subsequent Fair Value Loans" and together with the Initial Fair Value Loans, the "Fair Value Loans"). Accordingly, for the three months ended March 31, 2020, the Company did not have any loans receivable measured at amortized cost. Asset-backed notes issued prior to January 1, 2018 are accounted for at amortized cost, net. Loans that the Company designates for sale will continue to be accounted for as held for sale and recorded at the lower of cost or fair value until the loans receivable are sold. The table below compares the fair value of loans receivable and asset-backed notes to their contractual balances for the periods shown: March 31, 2020 December 31, 2019 (in thousands) Unpaid Principal Balance Fair Value Unpaid Principal Balance Fair Value Assets Loans receivable $ 1,833,159 $ 1,760,481 $ 1,800,418 $ 1,882,088 Liabilities Asset-backed notes 1,113,165 999,113 1,113,165 1,129,202 The Company calculates the fair value of the Fair Value Notes using independent pricing services and broker price indications, which are based on quoted prices for identical or similar notes, which are Level 2 input measures. The Company primarily uses a discounted cash flow model to estimate the fair value of Level 3 instruments based on the present value of estimated future cash flows. This model uses inputs that are inherently judgmental and reflect management’s best estimates of the assumptions a market participant would use to calculate fair value. The following tables present quantitative information about the significant unobservable inputs used for the Company’s Level 3 fair value measurements: March 31, 2020 December 31, 2019 Minimum Maximum Weighted Average (2) Minimum (3) Maximum (3) Weighted Average Remaining cumulative charge-offs (1) 7.43% 57.58% 14.56% * * 9.61% Remaining cumulative prepayments (1) —% 40.39% 26.00% * * 34.95% Average life (years) 0.17 1.91 0.90 * * 0.81 Discount rate - - 12.78% - - 7.77% (1) Figure disclosed as a percentage of outstanding principal balance. (2) Unobservable inputs were weighted by outstanding principal balance, which are grouped by risk (type of customer, original loan maturity terms). (3) The Company adopted ASU 2018-13 on a prospective basis, effective January 1, 2020, therefore, these disclosures are not required as of December 31, 2019. Fair value adjustments related to financial instruments where the fair value option has been elected are recorded through earnings for the three months ended March 31, 2020 and 2019 . Certain unobservable inputs may (in isolation) have either a directionally consistent or opposite impact on the fair value of the financial instrument for a given change in that input. When multiple inputs are used within the valuation techniques for loans, a change in one input in a certain direction may be offset by an opposite change from another input. The Company developed an internal model to estimate the Fair Value Loans. To generate future expected cash flows, the model combines receivable characteristics with assumptions about borrower behavior based on the Company’s historical loan performance. These cash flows are then discounted using a required rate of return that management estimates would be used by a market participant. The Company tested the fair value model by comparing modeled cash flows to historical loan performance to ensure that the model was complete, accurate and reasonable for the Company’s use. The Company also engaged a third party to create an independent fair value estimate for the Fair Value Loans, which provides a set of fair value marks using the Company’s historical loan performance data and whole loan sale prices to develop independent forecasts of borrower behavior. Their model generates expected cash flows which were then aggregated and compared to the Company’s within an acceptable range. The Company's internal valuation committee provides governance and oversight over the fair value pricing calculations and related financial statement disclosures. Additionally, this committee provides a challenge of the assumptions used and outputs of the model, including the appropriateness of such measures and periodically reviews the methodology and process to determine the fair value pricing. Any significant changes to the process must be approved by the committee. The table below presents a reconciliation of loans receivable at fair value on a recurring basis using significant unobservable inputs: Three Months Ended March 31, (in thousands) 2020 2019 Balance – beginning of period $ 1,882,088 $ 1,227,469 Adjustment upon adoption of ASU 2019-05 43,323 — Principal disbursements 371,433 355,114 Principal payments from customers (335,008 ) (197,055 ) Gross charge-offs (46,230 ) (23,250 ) Net increase (decrease) in fair value (155,125 ) 2,675 Balance – end of period $ 1,760,481 $ 1,364,953 As of March 31, 2020 , the aggregate fair value of loans that are 90 days or more past due and in non-accrual status is $2.3 million , and the aggregate unpaid principal balance for loans that are 90 days or more past due is $17.3 million . As of December 31, 2019 , the aggregate fair value of loans that are 90 days or more past due and in non-accrual status is $3.6 million , and the aggregate unpaid principal balance for loans that are 90 days or more past due is $15.8 million . Financial Instruments Disclosed But Not Carried at Fair Value The following table presents the carrying value and estimated fair values of financial assets and liabilities disclosed but not carried at fair value and the level within the fair value hierarchy: March 31, 2020 Carrying value Estimated fair value Estimated fair value (in thousands) Level 1 Level 2 Level 3 Assets Cash and cash equivalents $ 144,836 $ 144,836 $ 144,836 $ — $ — Restricted cash 61,258 61,258 61,258 — — Loans receivable at amortized cost, net (Note 5) — — — — — Loans held for sale (Note 6) 141 141 — — 141 Liabilities Accounts payable 7,843 7,843 7,843 — — Secured financing (Note 8) 279,999 264,789 — 264,789 — Asset-backed notes at amortized cost (Note 8) 199,602 189,011 — 189,011 — December 31, 2019 Carrying value Estimated fair value Estimated fair value (in thousands) Level 1 Level 2 Level 3 Assets Cash and cash equivalents $ 72,179 $ 72,179 $ 72,179 $ — $ — Restricted cash 63,962 63,962 63,962 — — Loans receivable at amortized cost, net (Note 5) 38,471 43,482 — — 43,482 Loans held for sale (Note 6) 715 772 — — 772 Liabilities Accounts payable 5,919 5,919 5,919 — — Secured financing (Note 8) 62,000 62,000 — 62,000 — Asset-backed notes at amortized cost (Note 8) 359,111 360,668 — 360,668 — The Company uses the following methods and assumptions to estimate fair value: • Cash, cash equivalents, restricted cash and accounts payable ‑ The carrying values of certain of the Company’s financial instruments, including cash and cash equivalents, restricted cash and accounts payable, approximate Level 1 fair values of these financial instruments due to their short-term nature. • Loans receivable ‑ The fair value of loans receivable recorded at amortized cost were estimated by discounting the future expected cash flows using a required rate of return that management estimates would be used by a market participant. • Loans held for sale ‑ The fair values of loans held for sale are based on a negotiated agreement with the purchaser. • Secured financing and asset-backed notes ‑ The fair values of secured financing and asset-backed notes recorded at carrying value have been calculated using discount rates equivalent to the weighted-average market yield of comparable debt securities. The Company's asset-backed notes are valued by independent pricing services and brokers using quoted prices for identical or similar notes, which are Level 2 input measures. There were no transfers in or out of Level 3 assets and liabilities for the three months ended March 31, 2020 and 2019 and the year ended December 31, 2019 . |
Leases, Commitments and Conting
Leases, Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies Disclosure [Text Block] | 15. Leases, Commitments and Contingencies Leases - The Company’s leases are primarily for real property consisting of retail locations and office space and have remaining lease terms of 10 years or less. The Company has elected the practical expedient to keep leases with terms of 12 months or less off the balance sheet as no recognition of a lease liability and a right-of-use asset is required. Operating lease expense is recognized on a straight-line basis over the lease term in "Technology and facilities" in the Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) . Most of the Company’s existing lease arrangements are classified as operating leases under the new standard. At the inception of a contract, the Company determines if the contract is or contains a lease. At the commencement date of a lease, the Company recognizes a lease liability equal to the present value of the lease payments and a right-of-use asset representing the Company's right to use the underlying asset for the duration of the lease term. The Company’s leases include options to extend or terminate the arrangement at the end of the original lease term. The Company generally does not include renewal or termination options in its assessment of the leases unless extension or termination for certain assets is deemed to be reasonably certain. Variable lease payments and short-term lease costs were deemed immaterial. The Company’s leases do not provide an explicit rate. The Company uses its contractual borrowing rate to determine lease discount rates. As of March 31, 2020 , maturities of lease liabilities, excluding short-term leases and leases on a month-to-month basis, were as follows: (in thousands) Operating Leases Lease expense 2020 (remaining nine months) $ 11,822 2021 13,331 2022 10,453 2023 9,004 2024 8,166 2025 6,201 Thereafter 1,407 Total lease payments 60,384 Imputed interest (6,126 ) Total leases $ 54,258 Sublease income 2020 (remaining nine months) $ (435 ) 2021 — 2022 and thereafter — Total lease payments (435 ) Imputed interest 2 Total sublease income $ (433 ) Net lease liabilities $ 53,825 Weighted average remaining lease term 4.8 years Weighted average discount rate 4.48 % As of December 31, 2019 , maturities of lease liabilities, excluding short-term leases and leases on a month-to-month basis, were as follows: (in thousands) Operating Leases Lease expense 2020 15,227 2021 12,439 2022 9,663 2023 8,340 2024 7,488 Thereafter 7,293 Total lease payments 60,450 Imputed interest (6,240 ) Total leases $ 54,210 Sublease income 2020 (861 ) 2021 and thereafter — Total lease payments (861 ) Imputed interest 8 Total sublease income $ (853 ) Net lease liabilities $ 53,357 Weighted average remaining lease term 5.0 years Weighted average discount rate 4.49 % Rental expenses under operating leases for the three months ended March 31, 2020 and 2019 , w as $5.2 million and $4.3 million , respectively. Purchase Commitment ‑ The Company has commitments to purchase information technology and communication services in the ordinary course of business, with various terms through 2023. These amounts are not reflective of the Company’s entire anticipated purchases under the related agreements; rather, they are determined based on the non-cancelable amounts to which the Company is contractually obligated. The Company’s purchase obligations are $4.9 million for the remainder of 2020 , $8.9 million in 2021 , $5.1 million in 2022 , $0.2 million in 2023 , and $0.0 million thereafter. Whole Loan Sale Program ‑ The Company has a commitment to sell to a third-party financial institution 10% of its unsecured loan originations that satisfy certain eligibility criteria, and an additional 5% at the Company’s sole option. For details regarding the whole loan sale program, refer to Note 6 , Loans Held for Sale . Access Loan Sale Program ‑ In July 2017, the Company entered into a whole loan sale transaction with a financial institution with a commitment to sell 100% of the originations pursuant to the Company’s Access Loan Program and service the sold loans. For details regarding the Access Loan Sale Program, refer to Note 6 , Loans Held for Sale . Unfunded Loan and Credit Card Commitments - Unfunded loan and credit card commitments at March 31, 2020 and December 31, 2019 were $2.7 million and $2.3 million , respectively. Litigation - On January 2, 2018, a complaint, captioned Opportune LLP v. Oportun, Inc. and Oportun, LLC, Civil Action No. 4:18-cv-00007 (the "Opportune Lawsuit"), was filed by plaintiff Opportune LLP in the United States District Court for the Southern District of Texas, against the Company and its wholly-owned subsidiary, Oportun, LLC. The complaint alleged various claims for trademark infringement, unfair competition, trademark dilution and misappropriation against the Company and Oportun, LLC and called for injunctive relief requiring the Company and Oportun, LLC to cease using its marks, as well as monetary damages related to the claims. In addition, on January 2, 2018, the plaintiff initiated a cancellation proceeding, Proceeding No. 92067634, before the Trademark Trial and Appeal Board seeking to cancel certain of the Company's trademarks, (the "Cancellation Proceeding" and, together with the Opportune Lawsuit, the "Opportune Matter"). On March 5, 2018, the Trademark Trial and Appeal Board granted the Company's motion to suspend the Cancellation Proceeding pending final disposition of the Opportune Lawsuit. On April 24, 2018, the District Court granted the Company's motion to partially dismiss the complaint, dismissing the plaintiff's misappropriation claim. On February 22, 2019, the plaintiff filed an amended complaint adding an additional claim under the Anti-Cybersquatting Protection Act to the remaining claims in the original complaint. On August 30, 2019, the Company filed a motion for summary judgment on all of the plaintiff's claims. On January 22, 2020, the District Court issued its decision denying the Company's motion for summary judgment. No trial date has been set. In connection with discussions regarding settlement of the Opportune Matter, the Company has recorded a liability of $1.9 million within Other liabilities and a corresponding insurance recovery receivable of $1.0 million within Other assets on the Condensed Consolidated Balance Sheets as of December 31, 2019. The income statement impact of $0.9 million was recorded through General, administrative and other on the Condensed Consolidated Statements of Operations and Comprehensive Income for the year ended December 31, 2019. Actual results could differ from these estimates. See Part II . Item 1. Legal Proceedings for additional information regarding legal proceedings in which the Company is involved. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2020 | |
Accounting Policies [Abstract] | |
Basis of Accounting, Policy [Policy Text Block] | Basis of Presentation ‑ The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). These statements are unaudited and reflect all normal, recurring adjustments that are, in management's opinion, necessary for the fair presentation of results. The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain prior-period financial information has been reclassified to conform to current period presentation. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this Quarterly Report on Form 10-Q should be read in conjunction with the audited consolidated financial statements and the related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2019 ("the Annual Report"), filed with the Securities and Exchange Commission ("SEC") on February 28, 2020. All share and per share amounts for all periods presented in the accompanying condensed consolidated financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect the Company's one-for-eleven reverse stock split. See "Initial Public Offering" above for additional information. |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates ‑ The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of income and expenses during the reporting period. These estimates are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from those estimates and assumptions. |
New Accounting Pronouncements, Policy [Policy Text Block] | Allowance for Loan Losses and Fair Value Option ‑ In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments. This guidance significantly changes the way entities are required to measure credit losses. Under the new standard, estimated credit losses are based upon an expected credit loss approach rather than an incurred loss approach that was previously required. In May 2019, the FASB issued ASU 2019-05, Financial Instruments-Credit Losses (Topic 326): Targeted Transition . This ASU provides an option to irrevocably elect the fair value option applied on an instrument-by-instrument basis for certain financial assets upon the adoption of Topic 326. In November 2019, the FASB issued ASU 2019-10, Financial Instruments - Credit Loss (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) , which deferred the effective date for public filers that are considered smaller reporting companies as defined by the SEC to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted in fiscal years beginning after December 15, 2018, including interim periods in those fiscal years. The Company elected to early adopt ASU 2016-13 and ASU 2019-05 effective January 1, 2020. The Company previously elected the fair value option for all loans originated after January 1, 2018. Upon adoption of ASU 2019-05, the Company elected the fair value option on all loans receivable originated prior to January 1, 2018 that were previously measured at amortized cost. As a result, adoption of ASU 2016-13 did not have impact on the Company's condensed consolidated financial statements and disclosures. The Company made an accounting policy election not to measure an allowance for credit losses on accrued interest receivable amounts as the Company writes off the uncollectible accrued interest receivable balance in a timely manner and makes relevant disclosures. The adoption of ASU 2019-05 and fair value election resulted in (i) the release of the remaining allowance for loan losses on Loans Receivable at Amortized Cost as of December 31, 2019; (ii) recognition of the unamortized net originations fee income as of December 31, 2019; and (iii) measurement of the remaining loans originated prior to January 1, 2018 at fair value. These adjustments resulted in an increase to opening retained earnings as of January 1, 2020 of approximately $4.8 million . ASU 2019-05 does not allow for the fair value option to be elected on our asset-backed notes carried at amortized cost. Fair Value Disclosures ‑ In August 2018, the FASB issued ASU 2018-13, Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement , which amends ASC 820, Fair Value Measurement . This ASU simplifies the disclosure requirements for fair value measurements. The Company adopted this ASU effective January 1, 2020. The simplified disclosure requirements included a new disclosure for the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements and the narrative description of measurement uncertainty. These new disclosure requirements were applied prospectively. Cloud Computing Arrangements - In August 2018, the FASB issued ASU 2018-15, Intangibles-Goodwill and Other-Internal-Use-Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. This ASU aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company adopted the amendments of this ASU effective January 1, 2020 on a prospective basis with no impact upon adoption. All eligible implementation costs related to cloud computing arrangements are now recorded as part of "prepaid expenses" within "Other assets" on the Condensed Consolidated Balance Sheets (Unaudited) . The amortization expense is presented in the same line on the income statement as the fees for the associated hosted service within "Operating expenses" on the Company's Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) , and the cash payments related to implementation of cloud computing arrangements are classified as "cash flows from operating activities" within the Condensed Consolidated Statements of Cash Flow (Unaudited) . Income Taxes - In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes . This ASU is intended to simplify the accounting for income taxes by removing certain exceptions to the general principles of accounting for income taxes and to improve the consistent application of GAAP for other areas of accounting for income taxes by clarifying and amending existing guidance. The ASU is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the effect that the new guidance will have on its consolidated financial statements and disclosures. Reference rate reform - In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this ASU provide optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform if certain criteria are met. An entity may elect to apply the amendments for contract modifications as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020. The amendments in this ASU must be applied prospectively for all eligible contract modifications. The Company is currently evaluating the effect that the new guidance will have on its consolidated financial statements and disclosures. |
Loans Receivable at Amortized_2
Loans Receivable at Amortized Cost, Net (Policies) | 3 Months Ended |
Mar. 31, 2020 | |
Receivables [Abstract] | |
Credit Loss, Financial Instrument [Policy Text Block] | Past Due Loans Receivable - In accordance with the Company’s policy, for loans recorded at amortized cost, income from interest and fees continues to be recorded for loans that are delinquent 90 days or more. The Company addresses the valuation risk on loans recorded at amortized cost that are delinquent 90 days or more by reserving them at 100% For loans receivable at amortized cost, the Company sets the allowance for loan losses on a total portfolio by analyzing historical charge-off rates for the loan portfolio and the credit quality indicators discussed earlier. A loan that has been classified as a TDR remains so until the loan is paid off or charged off. A TDR loan that misses its first two scheduled payments is charged off at the end of the month upon reaching 30 days ' delinquency. A TDR loan that makes the first two scheduled payments is charged off according to the Company’s normal charge-off policy at 120 days ' delinquency. For loans recorded at amortized cost, previously accrued but unpaid interest and fees are also written off when the loan is charged off upon reaching 120 days ' delinquency or when collection is not deemed probable. The Company’s proprietary credit scoring platform determines the amount and duration of the loan. The amount of the loan is determined based on the credit risk and cash flow of the individual. Lower risk individuals with higher cash flows are eligible for larger loans with longer duration. Higher risk individuals with lower cash flows are eligible for smaller loans with shorter duration. Larger loans typically have lower interest rates than smaller loans. After the loan is disbursed, the Company monitors the credit quality of its loans receivable on an ongoing and a total portfolio basis. The following is a credit quality indicator that the Company uses to monitor its exposure to credit risk, to evaluate allowance for loan losses and help set the Company’s strategy in granting future loans: • Delinquency Status ‑ The delinquency status of the Company’s loan receivables reflects, among other factors, changes in the mix of loans in the portfolio, the quality of receivables, the success of collection efforts and general economic conditions. |
Fair Value of Financial Instr_2
Fair Value of Financial Instruments (Policies) | 3 Months Ended |
Mar. 31, 2020 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Financial Instruments, Policy [Policy Text Block] | Fair value adjustments related to financial instruments where the fair value option has been elected are recorded through earnings for the three months ended March 31, 2020 and 2019 . Certain unobservable inputs may (in isolation) have either a directionally consistent or opposite impact on the fair value of the financial instrument for a given change in that input. When multiple inputs are used within the valuation techniques for loans, a change in one input in a certain direction may be offset by an opposite change from another input. The Company developed an internal model to estimate the Fair Value Loans. To generate future expected cash flows, the model combines receivable characteristics with assumptions about borrower behavior based on the Company’s historical loan performance. These cash flows are then discounted using a required rate of return that management estimates would be used by a market participant. The Company tested the fair value model by comparing modeled cash flows to historical loan performance to ensure that the model was complete, accurate and reasonable for the Company’s use. The Company also engaged a third party to create an independent fair value estimate for the Fair Value Loans, which provides a set of fair value marks using the Company’s historical loan performance data and whole loan sale prices to develop independent forecasts of borrower behavior. Their model generates expected cash flows which were then aggregated and compared to the Company’s within an acceptable range. The Company's internal valuation committee provides governance and oversight over the fair value pricing calculations and related financial statement disclosures. Additionally, this committee provides a challenge of the assumptions used and outputs of the model, including the appropriateness of such measures and periodically reviews the methodology and process to determine the fair value pricing. Any significant changes to the process must be approved by the committee. |
Earnings per Share (Tables)
Earnings per Share (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | Basic and diluted earnings (loss) per share are calculated as follows: Three Months Ended March 31, (in thousands, except share and per share data) 2020 2019 Net income (loss) $ (13,301 ) $ 14,614 Less: Net income allocated to participating securities (1) — (12,926 ) Net (loss) income attributable to common stockholders $ (13,301 ) $ 1,688 Basic weighted-average common shares outstanding 27,015,730 2,938,006 Weighted average effect of dilutive securities: Stock options — 317,433 Restricted stock units — 46,512 Warrants — 12,436 Diluted weighted-average common shares outstanding 27,015,730 3,314,387 Earnings (loss) per share: Basic $ (0.49 ) $ 0.57 Diluted $ (0.49 ) $ 0.51 (1) In a period of net income, both earnings and dividends (if any) are allocated to participating securities. In a period of net loss, only dividends (if any) are allocated to participating securities. |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] | The following common share equivalent securities have been excluded from the calculation of diluted weighted-average common shares outstanding because the effect is anti-dilutive for the periods presented: Three Months Ended March 31, 2020 2019 Stock options 4,086,128 — Restricted stock units 1,757,010 — Warrants 23,512 — Convertible preferred stock — 17,201,639 Total anti-dilutive common share equivalents 5,866,650 17,201,639 |
Variable Interest Entities (Tab
Variable Interest Entities (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Schedule of Variable Interest Entities | The following table represents the assets and liabilities of consolidated VIEs recorded on the Company’s Condensed Consolidated Balance Sheets (Unaudited) : March 31, December 31, (in thousands) 2020 2019 Consolidated VIE assets Restricted cash $ 25,963 $ 28,821 Loans receivable at fair value 1,693,903 1,745,465 Loans receivable at amortized cost — 41,747 Interest and fee receivable 17,274 15,874 Total VIE assets 1,737,140 1,831,907 Consolidated VIE liabilities Secured financing (1) 279,999 62,000 Asset-backed notes at fair value 999,113 1,129,202 Asset-backed notes at amortized cost (1) 200,000 360,001 Total VIE liabilities $ 1,479,112 $ 1,551,203 (1) Amounts exclude deferred financing costs. See Note 8 , Borrowings for additional information. |
Loans Receivable at Amortized_3
Loans Receivable at Amortized Cost, Net (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Receivables [Abstract] | |
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] | Loans receivable at amortized cost, net, consisted of the following: March 31, December 31, (in thousands) 2020 2019 Loans receivable at amortized cost $ — $ 42,546 Deferred origination costs and fees, net — (103 ) Allowance for loan losses — (3,972 ) Loans receivable at amortized cost, net $ — $ 38,471 |
Financing Receivable Credit Quality Indicators [Table Text Block] | The recorded investment in loans receivable at amortized cost based on this credit quality indicator was as follows: March 31, December 31, Credit Quality Indicator (in thousands) 2020 2019 Delinquency Status 30-59 days past due $ — $ 2,304 60-89 days past due — 1,615 90-119 days past due — 1,459 $ — $ 5,378 |
Financing Receivable, Past Due [Table Text Block] | The recorded investment in loans receivable at amortized cost that are 90 or more days delinquent and still accruing income from interest and fees were as follows: March 31, December 31, (in thousands) 2020 2019 Non-TDRs $ — $ 720 TDRs — 739 Total $ — $ 1,459 |
Financing Receivable, Troubled Debt Restructuring [Table Text Block] | The Company’s TDR loans receivable at amortized cost based on delinquency status were as follows: March 31, December 31, (in thousands) 2020 2019 TDRs current to 29 days delinquent $ — $ 6,367 TDRs 30 or more days delinquent — 2,462 Total $ — $ 8,829 When a loan recorded at amortized cost is restructured as a TDR, a portion of all of the accrued but unpaid interest and late fees may be forgiven. The following table shows the financial effects of TDRs that occurred during the periods indicated: Three Months Ended March 31, (in thousands) 2020 2019 Contractual interest and fees forgiven $ — $ — Information on TDRs that defaulted and were charged off during the periods indicated were as follows: Three Months Ended March 31, (in thousands) 2020 2019 Recorded investment in TDRs that subsequently defaulted and were charged off $ — $ 3,254 Unpaid interest and fees charged off — 419 |
Financing Receivable, Allowance for Credit Loss [Table Text Block] | Activity in the allowance for loan losses was as follows: Three Months Ended March 31, (in thousands) 2020 2019 Balance - beginning of period $ 3,972 $ 26,326 Adjustment upon adoption of ASU 2019-05 (3,972 ) — Provision (release) for loan losses — (366 ) Loans charged off — (12,083 ) Recoveries — 3,315 Balance - end of period $ — $ 17,192 |
Other Assets (Tables)
Other Assets (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Schedule of Other Assets [Table Text Block] | Other assets consist of the following: March 31, December 31, (in thousands) 2020 2019 Fixed assets Computer and office equipment $ 10,697 $ 10,432 Furniture and fixtures 10,805 10,768 Purchased software 4,900 4,527 Vehicles 79 171 Leasehold improvements 28,673 27,701 Total cost 55,154 53,599 Less: Accumulated depreciation (33,086 ) (30,765 ) Total fixed assets, net $ 22,068 $ 22,834 System development costs: System development costs $ 42,194 $ 36,795 Less: Accumulated amortization (20,624 ) (18,456 ) Total system development costs, net $ 21,570 $ 18,339 Servicer fee and whole loan receivables 2,295 6,621 Prepaid expenses 16,209 12,217 Tax receivable and other 17,974 15,197 Total other assets $ 80,116 $ 75,208 |
Borrowings (Tables)
Borrowings (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Line of Credit [Member] | |
Debt Instrument [Line Items] | |
Schedule of Debt [Table Text Block] | The following table presents information regarding the Company's Secured Financing facility: March 31, 2020 Variable Interest Entity Current Balance Commitment Amount Maturity Date Interest Rate (in thousands) Oportun Funding V, LLC $ 279,064 $ 400,000 10/1/2021 LIBOR (minimum of 0.00%) + 2.45% December 31, 2019 Variable Interest Entity Current Balance Commitment Amount Maturity Date Interest Rate (in thousands) Oportun Funding V, LLC $ 60,910 $ 400,000 10/1/2021 LIBOR (minimum of 0.00%) + 2.45% |
Secured Debt [Member] | |
Debt Instrument [Line Items] | |
Schedule of Debt [Table Text Block] | The Company elected the fair value option for all asset-backed notes issued on or after January 1, 2018. The following table presents information regarding asset-backed notes: March 31, 2020 Variable Interest Entity Initial note amount issued (1) Initial collateral balance (2) Current balance (1) Current collateral balance (2) Weighted average interest rate (3) Original revolving period (in thousands) Asset-backed notes recorded at fair value: Oportun Funding XIII, LLC (Series 2019-A) $ 279,412 $ 294,118 $ 216,255 $ 299,008 3.22 % 3 years Oportun Funding XII, LLC (Series 2018-D) 175,002 184,213 156,504 187,188 4.50 % 3 years Oportun Funding X, LLC (Series 2018-C) 275,000 289,474 245,320 294,090 4.39 % 3 years Oportun Funding IX, LLC (Series 2018-B) 225,001 236,854 195,355 240,866 4.09 % 3 years Oportun Funding VIII, LLC (Series 2018-A) 200,004 222,229 185,679 226,052 3.83 % 3 years Total asset-backed notes recorded at fair value $ 1,154,419 $ 1,226,888 $ 999,113 $ 1,247,204 Asset-backed notes recorded at amortized cost: Oportun Funding VII, LLC (Series 2017-B) $ 200,000 $ 222,231 $ 199,602 $ 225,867 3.51 % 3 years Total asset-backed notes recorded at amortized cost $ 200,000 $ 222,231 $ 199,602 $ 225,867 December 31, 2019 Variable Interest Entity Initial note amount issued (1) Initial collateral balance (2) Current balance (1) Current collateral balance (2) Weighted average interest rate (3) Original revolving period (in thousands) Asset-backed notes recorded at fair value: Oportun Funding XIII, LLC (Series 2019-A) $ 279,412 $ 294,118 $ 251,090 $ 299,813 3.22 % 3 years Oportun Funding XII, LLC (Series 2018-D) 175,002 184,213 178,980 187,447 4.50 % 3 years Oportun Funding X, LLC (Series 2018-C) 275,000 289,474 280,852 294,380 4.39 % 3 years Oportun Funding IX, LLC (Series 2018-B) 225,001 236,854 216,306 241,000 4.09 % 3 years Oportun Funding VIII, LLC (Series 2018-A) 200,004 222,229 201,974 225,945 3.83 % 3 years Total asset-backed notes recorded at fair value $ 1,154,419 $ 1,226,888 $ 1,129,202 $ 1,248,585 Asset-backed notes recorded at amortized cost: Oportun Funding VII, LLC (Series 2017-B) $ 200,000 $ 222,231 $ 199,413 $ 225,925 3.51 % 3 years Oportun Funding VI, LLC (Series 2017-A) 160,001 188,241 159,698 191,223 3.36 % 3 years Total asset-backed notes recorded at amortized cost $ 360,001 $ 410,472 $ 359,111 $ 417,148 (1) Initial note amount issued includes notes retained by the Company as applicable. The current balances are measured at fair value for asset-backed notes recorded at fair value and measured at carrying amount for asset-back notes recorded at amortized cost. (2) Includes the unpaid principal balance of loans receivable, cash, cash equivalents and restricted cash pledged by the Company. (3) Weighted average interest rate excludes notes retained by the Company. |
Other Liabilities (Tables)
Other Liabilities (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Other Liabilities Disclosure [Abstract] | |
Other Liabilities [Table Text Block] | Other liabilities consist of the following: March 31, December 31, (in thousands) 2020 2019 Accounts payable $ 7,843 $ 5,919 Accrued compensation 14,262 22,226 Accrued expenses 17,124 15,110 Taxes payable 1,022 4,233 Accrued interest 3,179 3,842 Other 820 976 Total other liabilities $ 44,250 $ 52,306 |
Equity Compensation and Other_2
Equity Compensation and Other Benefits (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Equity [Abstract] | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] | Stock-based Compensation - Total stock-based compensation expense included in the Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) is as follows: Three Months Ended March 31, (in thousands) 2020 2019 Technology and facilities $ 752 $ 329 Sales and marketing 30 20 Personnel 3,369 1,631 Total stock-based compensation $ 4,151 $ 1,980 |
Revenue (Tables)
Revenue (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Revenue from Contract with Customer [Abstract] | |
Interest Income and Interest Expense Disclosure [Table Text Block] | Interest Income - Total interest income included in the Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) is as follows: Three Months Ended March 31, (in thousands) 2020 2019 Interest income Interest on loans $ 148,522 $ 124,224 Fees on loans 2,178 2,522 Total interest income 150,700 126,746 |
Interest and Other Income [Table Text Block] | Non-interest Income - Total non-interest income included in the Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) is as follows: Three Months Ended March 31, (in thousands) 2020 2019 Non-interest income Gain on loan sales $ 7,532 $ 7,312 Servicing fees 4,451 3,548 Other income 745 722 Total non-interest income $ 12,728 $ 11,582 |
Fair Value of Financial Instr_3
Fair Value of Financial Instruments (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Fair Value Disclosures [Abstract] | |
Fair Value Option, Disclosures [Table Text Block] | The table below compares the fair value of loans receivable and asset-backed notes to their contractual balances for the periods shown: March 31, 2020 December 31, 2019 (in thousands) Unpaid Principal Balance Fair Value Unpaid Principal Balance Fair Value Assets Loans receivable $ 1,833,159 $ 1,760,481 $ 1,800,418 $ 1,882,088 Liabilities Asset-backed notes 1,113,165 999,113 1,113,165 1,129,202 |
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] | The following tables present quantitative information about the significant unobservable inputs used for the Company’s Level 3 fair value measurements: March 31, 2020 December 31, 2019 Minimum Maximum Weighted Average (2) Minimum (3) Maximum (3) Weighted Average Remaining cumulative charge-offs (1) 7.43% 57.58% 14.56% * * 9.61% Remaining cumulative prepayments (1) —% 40.39% 26.00% * * 34.95% Average life (years) 0.17 1.91 0.90 * * 0.81 Discount rate - - 12.78% - - 7.77% (1) Figure disclosed as a percentage of outstanding principal balance. (2) Unobservable inputs were weighted by outstanding principal balance, which are grouped by risk (type of customer, original loan maturity terms). (3) The Company adopted ASU 2018-13 on a prospective basis, effective January 1, 2020, therefore, these disclosures are not required as of December 31, 2019. |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] | The table below presents a reconciliation of loans receivable at fair value on a recurring basis using significant unobservable inputs: Three Months Ended March 31, (in thousands) 2020 2019 Balance – beginning of period $ 1,882,088 $ 1,227,469 Adjustment upon adoption of ASU 2019-05 43,323 — Principal disbursements 371,433 355,114 Principal payments from customers (335,008 ) (197,055 ) Gross charge-offs (46,230 ) (23,250 ) Net increase (decrease) in fair value (155,125 ) 2,675 Balance – end of period $ 1,760,481 $ 1,364,953 |
Fair Value, by Balance Sheet Grouping [Table Text Block] | The following table presents the carrying value and estimated fair values of financial assets and liabilities disclosed but not carried at fair value and the level within the fair value hierarchy: March 31, 2020 Carrying value Estimated fair value Estimated fair value (in thousands) Level 1 Level 2 Level 3 Assets Cash and cash equivalents $ 144,836 $ 144,836 $ 144,836 $ — $ — Restricted cash 61,258 61,258 61,258 — — Loans receivable at amortized cost, net (Note 5) — — — — — Loans held for sale (Note 6) 141 141 — — 141 Liabilities Accounts payable 7,843 7,843 7,843 — — Secured financing (Note 8) 279,999 264,789 — 264,789 — Asset-backed notes at amortized cost (Note 8) 199,602 189,011 — 189,011 — December 31, 2019 Carrying value Estimated fair value Estimated fair value (in thousands) Level 1 Level 2 Level 3 Assets Cash and cash equivalents $ 72,179 $ 72,179 $ 72,179 $ — $ — Restricted cash 63,962 63,962 63,962 — — Loans receivable at amortized cost, net (Note 5) 38,471 43,482 — — 43,482 Loans held for sale (Note 6) 715 772 — — 772 Liabilities Accounts payable 5,919 5,919 5,919 — — Secured financing (Note 8) 62,000 62,000 — 62,000 — Asset-backed notes at amortized cost (Note 8) 359,111 360,668 — 360,668 — |
Leases, Commitments and Conti_2
Leases, Commitments and Contingencies (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
Lessee, Operating Lease, Liability, Maturity [Table Text Block] | As of March 31, 2020 , maturities of lease liabilities, excluding short-term leases and leases on a month-to-month basis, were as follows: (in thousands) Operating Leases Lease expense 2020 (remaining nine months) $ 11,822 2021 13,331 2022 10,453 2023 9,004 2024 8,166 2025 6,201 Thereafter 1,407 Total lease payments 60,384 Imputed interest (6,126 ) Total leases $ 54,258 Sublease income 2020 (remaining nine months) $ (435 ) 2021 — 2022 and thereafter — Total lease payments (435 ) Imputed interest 2 Total sublease income $ (433 ) Net lease liabilities $ 53,825 Weighted average remaining lease term 4.8 years Weighted average discount rate 4.48 % As of December 31, 2019 , maturities of lease liabilities, excluding short-term leases and leases on a month-to-month basis, were as follows: (in thousands) Operating Leases Lease expense 2020 15,227 2021 12,439 2022 9,663 2023 8,340 2024 7,488 Thereafter 7,293 Total lease payments 60,450 Imputed interest (6,240 ) Total leases $ 54,210 Sublease income 2020 (861 ) 2021 and thereafter — Total lease payments (861 ) Imputed interest 8 Total sublease income $ (853 ) Net lease liabilities $ 53,357 Weighted average remaining lease term 5.0 years Weighted average discount rate 4.49 % |
Organization and Description _2
Organization and Description of the Business Initial Public Offering (Details) $ / shares in Units, $ in Millions | Sep. 30, 2019USD ($)$ / sharesshares | Sep. 26, 2019shares | Sep. 09, 2019 |
Subsidiary, Sale of Stock [Line Items] | |||
Shares Sold by Others Outside the Company | 2,314,144 | ||
Stockholders' Equity Note, Stock Split, Conversion Ratio | 0.0909 | ||
Preferred Stock [Member] | |||
Subsidiary, Sale of Stock [Line Items] | |||
Conversion of Stock, Shares Converted | 14,043,977 | ||
Conversion of Stock, Shares Issued | 3,969 | ||
Common Stock [Member] | |||
Subsidiary, Sale of Stock [Line Items] | |||
Conversion of Stock, Shares Issued | 19,075,167 | 3,969 | |
Warrant [Member] | |||
Subsidiary, Sale of Stock [Line Items] | |||
Conversion of Stock, Shares Issued | 23,512 | ||
Warrant [Member] | Series F-1 Preferred [Member] | |||
Subsidiary, Sale of Stock [Line Items] | |||
Conversion of Stock, Shares Converted | 9,090 | ||
IPO [Member] | |||
Subsidiary, Sale of Stock [Line Items] | |||
Stock Issued During Period, Shares, New Issues | 4,873,356 | ||
Shares Issued, Price Per Share | $ / shares | $ 15 | ||
Proceeds from Issuance Initial Public Offering | $ | $ 60.5 | ||
Payments for Underwriting Expense | $ | 5.1 | ||
Payments of Stock Issuance Costs | $ | $ 7.5 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies Details (Details) $ in Millions | Jan. 01, 2020USD ($) |
Accounting Policies [Abstract] | |
Cumulative Effect of New Accounting Principle in Period of Adoption | $ 4.8 |
Earnings per Share Earnings Per
Earnings per Share Earnings Per Share Calculation (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | ||
Net income (loss) | $ (13,301) | $ 14,614 |
Net income allocated to participating securities | 0 | (12,926) |
Net (loss) income attributable to common stockholders | $ (13,301) | $ 1,688 |
Weighted Average Number of Shares Outstanding, Basic | 27,015,730 | 2,938,006 |
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | 0 | 12,436 |
Weighted Average Number of Shares Outstanding, Diluted | 27,015,730 | 3,314,387 |
Earnings Per Share, Basic, Undistributed | $ (0.49) | $ 0.57 |
Earnings Per Share, Diluted, Undistributed | $ (0.49) | $ 0.51 |
Equity Option [Member] | ||
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | ||
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | 0 | 317,433 |
Restricted Stock Units (RSUs) [Member] | ||
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | ||
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | 0 | 46,512 |
Earnings per Share Anti-dilutiv
Earnings per Share Anti-dilutive Securities (Details) - shares | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 5,866,650 | 17,201,639 |
Share-based Payment Arrangement, Option [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 4,086,128 | 0 |
Restricted Stock Units (RSUs) [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 1,757,010 | 0 |
Securities Excluded from Computation of Diluted Earnings per Share, Amount | 0 | 455,821 |
Warrant [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 23,512 | 0 |
Convertible Preferred Stock [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 0 | 17,201,639 |
Variable Interest Entities (Det
Variable Interest Entities (Details) - USD ($) $ in Thousands | Mar. 31, 2020 | Dec. 31, 2019 |
Variable Interest Entity [Line Items] | ||
Variable Interest Entity, Consolidated, Assets, Pledged | $ 1,737,140 | $ 1,831,907 |
Variable Interest Entity, Consolidated, Liabilities, No Recourse | 1,479,112 | 1,551,203 |
Restricted Cash [Member] | ||
Variable Interest Entity [Line Items] | ||
Variable Interest Entity, Consolidated, Assets, Pledged | 25,963 | 28,821 |
Loans Receivable [Member] | ||
Variable Interest Entity [Line Items] | ||
Variable Interest Entity, Consolidated, Assets, Pledged | 1,693,903 | 1,745,465 |
Loans Receivable at Amortized Cost [Member] | ||
Variable Interest Entity [Line Items] | ||
Variable Interest Entity, Consolidated, Assets, Pledged | 0 | 41,747 |
Financing Receivable [Member] | ||
Variable Interest Entity [Line Items] | ||
Variable Interest Entity, Consolidated, Assets, Pledged | 17,274 | 15,874 |
Secured Financing [Member] | ||
Variable Interest Entity [Line Items] | ||
Variable Interest Entity, Consolidated, Liabilities, No Recourse | 279,999 | 62,000 |
Liabilities at Fair Value [Member] | ||
Variable Interest Entity [Line Items] | ||
Variable Interest Entity, Consolidated, Liabilities, No Recourse | 999,113 | 1,129,202 |
Asset-backed Notes at Amortized Cost [Member] | ||
Variable Interest Entity [Line Items] | ||
Variable Interest Entity, Consolidated, Liabilities, No Recourse | $ 200,000 | $ 360,001 |
Loans Receivable at Amortized_4
Loans Receivable at Amortized Cost, Net Loans Receivable (Details) - USD ($) | Mar. 31, 2020 | Dec. 31, 2019 | Mar. 31, 2019 | Dec. 31, 2018 |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Loans receivable at amortized cost | $ 0 | $ 42,546,000 | ||
Unamortized deferred origination costs and fees, net | 0 | (103,000) | ||
Allowance for loan losses | 0 | (3,972,000) | $ (17,192,000) | $ (26,326,000) |
Loans receivable at amortized cost, net | 0 | 38,471,000 | ||
Unpaid interest on amortized cost loans | 0 | 300,000 | ||
Unpaid late fees | 0 | |||
Consumer Loan [Member] | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Loans receivable at amortized cost | 0 | 42,546,000 | ||
Unamortized deferred origination costs and fees, net | 0 | (103,000) | ||
Allowance for loan losses | 0 | (3,972,000) | ||
Loans receivable at amortized cost, net | $ 0 | $ 38,471,000 |
Loans Receivable at Amortized_5
Loans Receivable at Amortized Cost, Net Credit Quality Indicators (Details) - USD ($) | 3 Months Ended | ||
Mar. 31, 2020 | Mar. 31, 2019 | Dec. 31, 2019 | |
Financing Receivable, Credit Quality Indicator [Line Items] | |||
Loans and Leases Receivable, before Fees, Gross | $ 0 | $ 42,546,000 | |
Financing Receivable, Threshold Period Past Due | 90 years | ||
Financing Receivable, Reserve Rate, 90 Days Past Due | 100.00% | ||
Financing Receivables, Troubled Debt Restructuring, Percentage of Loans at Cost | 21.00% | ||
Financing Receivables, Impaired, Troubled Debt Restructuring, Origination Fees Written Off | $ 0 | ||
Financing Receivable, Threshold Period Past Due, Writeoff | 30 years | ||
Financing Receivable, Threshold Period Past Due, Writeoff, Two Payments | 120 years | ||
Consumer Loan [Member] | |||
Financing Receivable, Credit Quality Indicator [Line Items] | |||
Loans and Leases Receivable, before Fees, Gross | $ 0 | $ 42,546,000 | |
Consumer Loan [Member] | Troubled Debt Restructuring [Member] | |||
Financing Receivable, Credit Quality Indicator [Line Items] | |||
Loans and Leases Receivable, before Fees, Gross | 0 | 8,829,000 | |
Consumer Loan [Member] | Financial Asset, 1 to 29 Days Past Due [Member] | Troubled Debt Restructuring [Member] | |||
Financing Receivable, Credit Quality Indicator [Line Items] | |||
Loans and Leases Receivable, before Fees, Gross | 0 | 6,367,000 | |
Consumer Loan [Member] | Financial Asset, 30 to 59 Days Past Due [Member] | |||
Financing Receivable, Credit Quality Indicator [Line Items] | |||
Loans and Leases Receivable, before Fees, Gross | 0 | 2,304,000 | |
Consumer Loan [Member] | Financial Asset, 60 to 89 Days Past Due [Member] | |||
Financing Receivable, Credit Quality Indicator [Line Items] | |||
Loans and Leases Receivable, before Fees, Gross | 0 | 1,615,000 | |
Consumer Loan [Member] | Financial Asset, Equal to or Greater than 90 Days Past Due [Member] | |||
Financing Receivable, Credit Quality Indicator [Line Items] | |||
Loans and Leases Receivable, before Fees, Gross | 0 | 1,459,000 | |
Consumer Loan [Member] | Financial Asset, Equal to or Greater than 90 Days Past Due [Member] | Troubled Debt Restructuring [Member] | |||
Financing Receivable, Credit Quality Indicator [Line Items] | |||
Loans and Leases Receivable, before Fees, Gross | 0 | 739,000 | |
Consumer Loan [Member] | Financial Asset, Equal to or Greater than 90 Days Past Due [Member] | non-Troubled Debt Restructuring [Member] | |||
Financing Receivable, Credit Quality Indicator [Line Items] | |||
Loans and Leases Receivable, before Fees, Gross | 0 | 720,000 | |
Consumer Loan [Member] | Financial Asset, 30 Days or More Past Due [Member] | Troubled Debt Restructuring [Member] | |||
Financing Receivable, Credit Quality Indicator [Line Items] | |||
Loans and Leases Receivable, before Fees, Gross | 0 | 2,462,000 | |
Consumer Loan [Member] | Total Delinquent Principle [Member] | |||
Financing Receivable, Credit Quality Indicator [Line Items] | |||
Loans and Leases Receivable, before Fees, Gross | $ 0 | $ 5,378,000 |
Loans Receivable at Amortized_6
Loans Receivable at Amortized Cost, Net Troubled Debt Restructuring Activity (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||
Financing Receivables, Impaired, Troubled Debt Restructuring, Write-down | $ 0 | $ 0 |
Consumer Loan [Member] | ||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||
Financing Receivable, Troubled Debt Restructuring, Subsequent Default | 0 | 3,254 |
Financing Receivable, Troubled Debt Restructuring, Subsequent Interest and Fees Charged Off | $ 0 | $ 419 |
Loans Receivable at Amortized_7
Loans Receivable at Amortized Cost, Net Allowance for Loan Losses (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Allowance for Loan and Lease Losses [Roll Forward] | ||
Balance - beginning of period | $ 3,972 | $ 26,326 |
Allowance for Loan and Lease Losses, Adjustments, Other | (3,972) | 0 |
Provision (release) for loan losses | 0 | (366) |
Loans charged off | 0 | (12,083) |
Recoveries | 0 | 3,315 |
Balance - end of period | $ 0 | $ 17,192 |
Loans Held for Sale (Details)
Loans Held for Sale (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Transfers and Servicing [Abstract] | ||
Originations of loans sold and held for sale | $ 74,530 | $ 70,734 |
Gain (Loss) on Sales of Consumer Loans | 7,532 | 7,312 |
Contractually Specified Servicing Fees, Amount | $ 4,451 | $ 3,548 |
Minimum Loan Sale Rate, Whole Loan Sale Program | 10.00% | |
Incremental Optional Loan Sale Rate, Whole Loan Sale Program | 5.00% | |
Minimum Loan Sale Rate, Access Loan Program | 100.00% |
Other Assets (Details)
Other Assets (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2020 | Mar. 31, 2019 | Dec. 31, 2019 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |||
Computer and office equipment | $ 10,697 | $ 10,432 | |
Furniture and fixtures | 10,805 | 10,768 | |
Purchased software | 4,900 | 4,527 | |
Vehicles | 79 | 171 | |
Leasehold improvements | 28,673 | 27,701 | |
Total cost | 55,154 | 53,599 | |
Property, plant, and equipment, accumulated depreciation | (33,086) | (30,765) | |
Total fixed assets, net | 22,068 | 22,834 | |
System Development Costs | 42,194 | 36,795 | |
System development costs, accumulated amortization | (20,624) | (18,456) | |
Total system development costs, net | 21,570 | 18,339 | |
Servicer fee and whole loan receivables | 2,295 | 6,621 | |
Prepaid expenses | 16,209 | 12,217 | |
Other | 17,974 | 15,197 | |
Other Assets | 80,116 | $ 75,208 | |
Depreciation | 2,500 | $ 1,700 | |
Capitalized Computer Software, Amortization | 2,200 | 900 | |
Capitalized Computer Software, Additions | $ 5,400 | $ 2,600 |
Borrowings (Details)
Borrowings (Details) - USD ($) $ in Thousands | Aug. 01, 2019 | Dec. 10, 2018 | Dec. 07, 2018 | Oct. 22, 2018 | Jul. 09, 2018 | Mar. 08, 2018 | Oct. 11, 2017 | Jun. 08, 2017 | Mar. 31, 2020 | Mar. 31, 2019 | Dec. 31, 2019 |
Debt Instrument [Line Items] | |||||||||||
Warehouse Agreement Borrowings | $ 279,064 | $ 60,910 | |||||||||
Secured Debt, Fair Value | 999,113 | 1,129,202 | |||||||||
Asset-backed notes at amortized cost | 199,602 | 359,111 | |||||||||
Line of Credit [Member] | Secured Warehouse Facility [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Warehouse Agreement Borrowings | 279,064 | 60,910 | |||||||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 400,000 | $ 400,000 | |||||||||
Line of Credit Facility, Expiration Date | Oct. 1, 2021 | ||||||||||
Debt Instrument, Description of Variable Rate Basis | LIBOR (minimum of 0.00%) + 2.45% | LIBOR (minimum of 0.00%) + 2.45% | |||||||||
Line of Credit Facility, Covenant Compliance | Yes | Yes | |||||||||
Secured Debt [Member] | Asset-backed Notes Series 2019-A [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Covenant Compliance | Yes | Yes | |||||||||
Secured Debt [Member] | Asset-Backed Notes Series 2018-D [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Covenant Compliance | Yes | Yes | |||||||||
Secured Debt [Member] | Asset-Backed Notes Series 2018-C [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Covenant Compliance | Yes | Yes | |||||||||
Secured Debt [Member] | Asset-Backed Notes Series 2018-B [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Covenant Compliance | Yes | Yes | |||||||||
Secured Debt [Member] | Asset-Backed Notes Series 2018-A [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Covenant Compliance | Yes | Yes | |||||||||
Secured Debt [Member] | Asset-Backed Notes Series 2017-B [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Covenant Compliance | Yes | Yes | |||||||||
Secured Debt [Member] | Asset-Backed Notes Series 2017-A [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Covenant Compliance | Yes | ||||||||||
Fair Value [Member] | Secured Debt [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Face Amount | $ 1,154,419 | $ 1,154,419 | |||||||||
Secured Debt, Fair Value | 999,113 | 1,129,202 | |||||||||
Fair Value [Member] | Secured Debt [Member] | Initial Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | 1,226,888 | 1,226,888 | |||||||||
Fair Value [Member] | Secured Debt [Member] | Current Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | 1,247,204 | 1,248,585 | |||||||||
Fair Value [Member] | Secured Debt [Member] | Asset-backed Notes Series 2019-A [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Face Amount | $ 279,412 | ||||||||||
Secured Debt, Fair Value | 216,255 | 251,090 | |||||||||
Debt, Weighted Average Interest Rate | 3.22% | ||||||||||
Debt Instrument, Term | 3 years | ||||||||||
Fair Value [Member] | Secured Debt [Member] | Asset-backed Notes Series 2019-A [Member] | Initial Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | $ 294,118 | ||||||||||
Fair Value [Member] | Secured Debt [Member] | Asset-backed Notes Series 2019-A [Member] | Current Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | 299,008 | 299,813 | |||||||||
Fair Value [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2018-D [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Face Amount | $ 175,002 | ||||||||||
Secured Debt, Fair Value | 156,504 | 178,980 | |||||||||
Debt, Weighted Average Interest Rate | 4.50% | ||||||||||
Debt Instrument, Term | 3 years | ||||||||||
Fair Value [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2018-D [Member] | Initial Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | $ 184,213 | ||||||||||
Fair Value [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2018-D [Member] | Current Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | 187,188 | 187,447 | |||||||||
Fair Value [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2018-C [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Face Amount | $ 275,000 | ||||||||||
Secured Debt, Fair Value | 245,320 | 280,852 | |||||||||
Debt, Weighted Average Interest Rate | 4.39% | ||||||||||
Debt Instrument, Term | 3 years | ||||||||||
Fair Value [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2018-C [Member] | Initial Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | $ 289,474 | ||||||||||
Fair Value [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2018-C [Member] | Current Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | 294,090 | 294,380 | |||||||||
Fair Value [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2018-B [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Face Amount | $ 225,001 | ||||||||||
Secured Debt, Fair Value | 195,355 | 216,306 | |||||||||
Debt, Weighted Average Interest Rate | 4.09% | ||||||||||
Debt Instrument, Term | 3 years | ||||||||||
Fair Value [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2018-B [Member] | Initial Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | $ 236,854 | ||||||||||
Fair Value [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2018-B [Member] | Current Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | 240,866 | 241,000 | |||||||||
Fair Value [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2018-A [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Face Amount | $ 200,004 | ||||||||||
Secured Debt, Fair Value | 185,679 | 201,974 | |||||||||
Debt, Weighted Average Interest Rate | 3.83% | ||||||||||
Debt Instrument, Term | 3 years | ||||||||||
Fair Value [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2018-A [Member] | Initial Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | $ 222,229 | ||||||||||
Fair Value [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2018-A [Member] | Current Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | 226,052 | 225,945 | |||||||||
Amortized Cost [Member] | Secured Debt [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Face Amount | 200,000 | 360,001 | |||||||||
Asset-backed notes at amortized cost | 199,602 | 359,111 | |||||||||
Amortized Cost [Member] | Secured Debt [Member] | Initial Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | 222,231 | 410,472 | |||||||||
Amortized Cost [Member] | Secured Debt [Member] | Current Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | 225,867 | 417,148 | |||||||||
Amortized Cost [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2017-B [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Face Amount | $ 200,000 | ||||||||||
Asset-backed notes at amortized cost | 199,602 | 199,413 | |||||||||
Debt, Weighted Average Interest Rate | 3.51% | ||||||||||
Debt Instrument, Term | 3 years | ||||||||||
Amortized Cost [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2017-B [Member] | Initial Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | $ 222,231 | ||||||||||
Amortized Cost [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2017-B [Member] | Current Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | $ 225,867 | 225,925 | |||||||||
Amortized Cost [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2017-A [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Face Amount | $ 160,001 | ||||||||||
Asset-backed notes at amortized cost | 159,698 | ||||||||||
Debt, Weighted Average Interest Rate | 3.36% | ||||||||||
Debt Instrument, Term | 3 years | ||||||||||
Amortized Cost [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2017-A [Member] | Initial Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | $ 188,241 | ||||||||||
Amortized Cost [Member] | Secured Debt [Member] | Asset-Backed Notes Series 2017-A [Member] | Current Collateral [Member] | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt Instrument, Collateral Amount | $ 191,223 |
Other Liabilities (Details)
Other Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2020 | Dec. 31, 2019 |
Other Liabilities Disclosure [Abstract] | ||
Accounts payable | $ 7,843 | $ 5,919 |
Accrued compensation | 14,262 | 22,226 |
Accrued expenses | 17,124 | 15,110 |
Taxes payable | 1,022 | 4,233 |
Accrued interest | 3,179 | 3,842 |
Other | 820 | 976 |
Other Liabilities | $ 44,250 | $ 52,306 |
Stockholders' Equity (Details)
Stockholders' Equity (Details) - USD ($) $ / shares in Units, $ in Thousands | Sep. 30, 2019 | Sep. 26, 2019 | Mar. 31, 2020 | Dec. 31, 2019 |
Class of Stock [Line Items] | ||||
Preferred Stock, Shares Authorized | 100,000,000 | 100,000,000 | ||
Common Stock, Shares Authorized | 1,000,000,000 | 1,000,000,000 | ||
Common Stock, Par or Stated Value Per Share | $ 0.0001 | $ 0.0001 | ||
Common Stock, Shares, Issued | 27,403,279 | 27,262,639 | ||
Common Stock, Shares, Outstanding | 27,143,797 | 27,003,157 | ||
Treasury Stock, Common, Shares | 259,482 | 259,482 | ||
Preferred Stock [Member] | ||||
Class of Stock [Line Items] | ||||
Conversion of Stock, Shares Converted | 14,043,977 | |||
Conversion of Stock, Shares Issued | 3,969 | |||
Common Stock [Member] | ||||
Class of Stock [Line Items] | ||||
Conversion of Stock, Shares Issued | 19,075,167 | 3,969 | ||
Common Stock [Member] | Series G Preferred [Member] | ||||
Class of Stock [Line Items] | ||||
Conversion of Stock, Shares Issued | 1,873,355 | |||
Dividends, Preferred Stock, Paid-in-kind | $ 37,500 | |||
Warrant [Member] | ||||
Class of Stock [Line Items] | ||||
Conversion of Stock, Shares Issued | 23,512 | |||
Warrant [Member] | Series F-1 Preferred [Member] | ||||
Class of Stock [Line Items] | ||||
Conversion of Stock, Shares Converted | 9,090 | |||
Warrant [Member] | Series G Preferred [Member] | ||||
Class of Stock [Line Items] | ||||
Conversion of Stock, Shares Converted | 15,869 |
Equity Compensation and Other_3
Equity Compensation and Other Benefits Share-based Payments (Details) - USD ($) $ in Thousands | Mar. 04, 2020 | Sep. 30, 2019 | Sep. 25, 2019 | Aug. 22, 2019 | Mar. 31, 2020 | Mar. 31, 2019 | Dec. 31, 2019 |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Annual Share Increase | 726,186 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate | 15.00% | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent | 85.00% | ||||||
Share-based Payment Arrangement, Expense | $ 7,900 | $ 4,151 | $ 1,980 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 8,677,294 | ||||||
Employee Stock Ownership Plan (ESOP), Shares in ESOP | 996,217 | ||||||
Share-based Payment Arrangement, Amount Capitalized | $ 100 | 100 | |||||
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation | $ 700 | 0 | |||||
Option on Securities [Member] | |||||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 10 years | ||||||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $ 14,400 | $ 10,100 | |||||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition | 3 years | 2 years 4 months 24 days | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period | 1,040,154 | ||||||
Restricted Stock Units (RSUs) [Member] | |||||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||||||
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount | $ 35,800 | $ 21,200 | |||||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition | 3 years 2 months 12 days | 3 years | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) | 455,218 | ||||||
Share-based Payment Arrangement, Plan Modification, Incremental Cost | $ 3,200 | ||||||
Technology and Facilities [Member] | |||||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||||||
Share-based Payment Arrangement, Expense | $ 752 | 329 | |||||
Sales and Marketing [Member] | |||||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||||||
Share-based Payment Arrangement, Expense | 30 | 20 | |||||
Personnel [Member] | |||||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||||||
Share-based Payment Arrangement, Expense | $ 3,369 | $ 1,631 | |||||
Share-based Payment Arrangement, Tranche One [Member] | Option on Securities [Member] | |||||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 25.00% | ||||||
Share-based Payment Arrangement, Tranche One [Member] | Restricted Stock Units (RSUs) [Member] | |||||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 25.00% | ||||||
2019 Equity Incentive Plan [Member] | |||||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized | 1,350,157 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase Percentage of Outstanding Stock | 5.00% | ||||||
2019 Employee Stock Purchase Plan [Member] | |||||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized | 270,031 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase Percentage of Outstanding Stock | 1.00% |
Revenue (Details)
Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Revenue from Contract with Customer [Abstract] | ||
Interest income | $ 148,522 | $ 124,224 |
Fees on loans | 2,178 | 2,522 |
Total interest income | 150,700 | 126,746 |
Gain on loan sales | 7,532 | 7,312 |
Servicing fees | 4,451 | 3,548 |
Other Income | 745 | 722 |
Total non-interest income | $ 12,728 | $ 11,582 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Income Tax Disclosure [Abstract] | ||
Income Tax Expense (Benefit) | $ (4,715) | $ 5,354 |
Effective tax rate | 26.20% | 26.80% |
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense |
Fair Value of Financial Instr_4
Fair Value of Financial Instruments Financial Instruments at Fair Value (Details) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2020USD ($) | Mar. 31, 2019USD ($) | Dec. 31, 2019USD ($) | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Adjustment upon adoption of ASU 2019-05 | $ 43,323 | $ 0 | |
Loans receivable, unpaid principal balance | 1,833,159 | $ 1,800,418 | |
Loans receivable, fair value | 1,760,481 | 1,882,088 | |
Asset-backed notes, unpaid principal balance | 1,113,165 | 1,113,165 | |
Asset-backed notes, fair value | 999,113 | 1,129,202 | |
Fair Value, Option, Loans Held as Assets, 90 Days or More Past Due | 2,300 | 3,600 | |
Fair Value, Option, Principal Balance of Loans Held as Assets, 90 Days or More Past Due | $ 17,300 | $ 15,800 | |
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Default Rate [Member] | Minimum [Member] | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Loans Held as Assets, Measurement Input | 0.0743 | ||
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Default Rate [Member] | Maximum [Member] | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Loans Held as Assets, Measurement Input | 0.5758 | ||
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Default Rate [Member] | Weighted Average [Member] | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Loans Held as Assets, Measurement Input | 0.1456 | 0.0961 | |
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Prepayment Rate [Member] | Minimum [Member] | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Loans Held as Assets, Measurement Input | 0 | ||
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Prepayment Rate [Member] | Maximum [Member] | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Loans Held as Assets, Measurement Input | 0.4039 | ||
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Prepayment Rate [Member] | Weighted Average [Member] | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Loans Held as Assets, Measurement Input | 0.2600 | 0.3495 | |
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Expected Term [Member] | Minimum [Member] | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Loans Held as Assets, Measurement Input | 0.17 | ||
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Expected Term [Member] | Maximum [Member] | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Loans Held as Assets, Measurement Input | 1.91 | ||
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Expected Term [Member] | Weighted Average [Member] | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Loans Held as Assets, Measurement Input | 0.90 | 0.81 | |
Fair Value, Inputs, Level 3 [Member] | Measurement Input, Discount Rate [Member] | Weighted Average [Member] | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Loans Held as Assets, Measurement Input | 0.1278 | 0.0777 | |
Loans Receivable [Member] | Fair Value, Inputs, Level 3 [Member] | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
Balance - beginning of period | $ 1,882,088 | 1,227,469 | |
Principal disbursements of loans receivable at fair value | 371,433 | 355,114 | |
Principal payments from customers | (335,008) | (197,055) | |
Charge-offs | (46,230) | (23,250) | |
Net increase in fair value | (155,125) | 2,675 | |
Balance - end of period | $ 1,760,481 | $ 1,364,953 |
Fair Value of Financial Instr_5
Fair Value of Financial Instruments Financial Instruments at Amortized Cost (Details) - USD ($) $ in Thousands | Mar. 31, 2020 | Dec. 31, 2019 |
Reported Value Measurement [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and cash equivalents | $ 144,836 | $ 72,179 |
Restricted cash | 61,258 | 63,962 |
Loans receivable at amortized cost | 0 | 38,471 |
Loans held for sale | 141 | 715 |
Accounts payable | 7,843 | 5,919 |
Secured financing | 279,999 | 62,000 |
Asset-backed notes at amortized cost | 199,602 | 359,111 |
Estimate of Fair Value Measurement [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and cash equivalents | 144,836 | 72,179 |
Restricted cash | 61,258 | 63,962 |
Loans receivable at amortized cost | 0 | 43,482 |
Loans held for sale | 141 | 772 |
Accounts payable | 7,843 | 5,919 |
Secured financing | 264,789 | 62,000 |
Asset-backed notes at amortized cost | 189,011 | 360,668 |
Fair Value, Inputs, Level 1 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and cash equivalents | 144,836 | 72,179 |
Restricted cash | 61,258 | 63,962 |
Loans receivable at amortized cost | 0 | 0 |
Loans held for sale | 0 | 0 |
Accounts payable | 7,843 | 5,919 |
Secured financing | 0 | 0 |
Asset-backed notes at amortized cost | 0 | 0 |
Fair Value, Inputs, Level 2 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Restricted cash | 0 | 0 |
Loans receivable at amortized cost | 0 | 0 |
Loans held for sale | 0 | 0 |
Accounts payable | 0 | 0 |
Secured financing | 264,789 | 62,000 |
Asset-backed notes at amortized cost | 189,011 | 360,668 |
Fair Value, Inputs, Level 3 [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Restricted cash | 0 | 0 |
Loans receivable at amortized cost | 0 | 43,482 |
Loans held for sale | 141 | 772 |
Accounts payable | 0 | 0 |
Secured financing | 0 | 0 |
Asset-backed notes at amortized cost | $ 0 | $ 0 |
Leases, Commitments and Conti_3
Leases, Commitments and Contingencies (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | Dec. 31, 2019 | |
Commitments and Contingencies Disclosure [Abstract] | |||
Maximum Remaining Lease Term, Retail and Office | 10 years | ||
2020 (remaining nine months) | $ 11,822 | ||
Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months | 13,331 | $ 15,227 | |
Lessee, Operating Lease, Liability, Payments, Due Year Two | 10,453 | 12,439 | |
Lessee, Operating Lease, Liability, Payments, Due Year Three | 9,004 | 9,663 | |
Lessee, Operating Lease, Liability, Payments, Due Year Four | 8,166 | 8,340 | |
Lessee, Operating Lease, Liability, Payments, Due Year Five | 6,201 | 7,488 | |
Lessee, Operating Lease, Liability, Payments, Due after Year Five | 1,407 | 7,293 | |
Total lease payments | 60,384 | 60,450 | |
Lessee, Operating Lease, Liability, Imputed Interest | (6,126) | (6,240) | |
Lessee, Operating Lease, Liability, Payments, Due Net of Imputed Interest | 54,258 | 54,210 | |
2020 (remaining nine months) | (435) | ||
Lessor, Operating Lease, Payments to be Received, Next Twelve Months | 0 | (861) | |
Lessor, Operating Lease, Payments to be Received, Thereafter | 0 | 0 | |
Total sublease income | (435) | (861) | |
Lessor, Operating Lease, Imputed Interest | 2 | 8 | |
Lessor, Operating Lease, Payments to be Received Net of Imputed Interest | (433) | (853) | |
Operating Lease, Liability | $ 53,825 | $ 53,357 | |
Operating Lease, Weighted Average Remaining Lease Term | 4 years 9 months 18 days | 5 years | |
Operating Lease, Weighted Average Discount Rate, Percent | 4.48% | 4.49% | |
Operating Lease, Expense | $ 5,200 | $ 4,300 | |
Purchase Obligation, Future Minimum Payments, Remainder of Fiscal Year | 4,900 | ||
Purchase Obligation, Due in Next Twelve Months | 8,900 | ||
Purchase Obligation, Due in Second Year | 5,100 | ||
Purchase Obligation, Due in Third Year | 200 | ||
Purchase Obligation, Due after Fifth Year | $ 0 | ||
Minimum Loan Sale Rate, Whole Loan Sale Program | 10.00% | ||
Incremental Optional Loan Sale Rate, Whole Loan Sale Program | 5.00% | ||
Minimum Loan Sale Rate, Access Loan Program | 100.00% | ||
Other Commitment | $ 2,700 | $ 2,300 | |
Estimated Litigation Liability | 1,900 | ||
Insurance Settlements Receivable | 1,000 | ||
Litigation Settlement, Expense | $ 900 |